APPLICATION_ID,ACTIVITY,ADMINISTERING_IC,APPLICATION_TYPE,ARRA_FUNDED,AWARD_NOTICE_DATE,BUDGET_START,BUDGET_END,CFDA_CODE,CORE_PROJECT_NUM,ED_INST_TYPE,OPPORTUNITY NUMBER,FULL_PROJECT_NUM,FUNDING_ICs,FUNDING_MECHANISM,FY,IC_NAME,NIH_SPENDING_CATS,ORG_CITY,ORG_COUNTRY,ORG_DEPT,ORG_DISTRICT,ORG_DUNS,ORG_FIPS,ORG_IPF_CODE,ORG_NAME,ORG_STATE,ORG_ZIPCODE,PHR,PI_IDS,PI_NAMEs,PROGRAM_OFFICER_NAME,PROJECT_START,PROJECT_END,PROJECT_TERMS,PROJECT_TITLE,SERIAL_NUMBER,STUDY_SECTION,STUDY_SECTION_NAME,SUBPROJECT_ID,SUFFIX,SUPPORT_YEAR,DIRECT_COST_AMT,INDIRECT_COST_AMT,TOTAL_COST,TOTAL_COST_SUB_PROJECT
11221081,N02,DA,NA,N,NA,NA,NA,NA,75N95023D00027,NA,NA,75N95023D00027-0-759502400008-1,NCATS:5487858\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,DENVER,UNITED STATES,NA,01,362130952,US,10065762,"PALANTIR TECHNOLOGIES, INC.",CO,802021866,NA,80002116 (contact),"ZAVERTNIK, BRIAN  (contact)",NA,2024-09-28,2025-09-27,Advisory Committees;Award;Clinical;Clinical and Translational Science Awards;Clinical Data;Clinical Research;cloud based;cohort;Collaborations;COVID-19;Data;Data Aggregation;Data Analytics;data de-identification;data enclave;Data Set;Dedications;Development;Environment;Institution;member;National Center for Advancing Translational Sciences;National Institute of General Medical Sciences;Personally Identifiable Information;Persons;privacy protection;programs;Research;Secure;synthetic data;Translational Research;United States National Institutes of Health,"NCATS: SECURE PLATFORMS SUPPORT FOR THE N3C, NIDAP, AND ASPR",0,NA,NA,NA,NA,NA,NA,NA,5487858,NA
11221082,N02,DA,NA,N,NA,NA,NA,NA,75N95023D00027,NA,NA,75N95023D00027-0-759502400002-1,NCATS:4685560\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,DENVER,UNITED STATES,NA,01,362130952,US,10065762,"PALANTIR TECHNOLOGIES, INC.",CO,802021866,NA,79688686 (contact),"ZAVERTNIK, BRIAN  (contact)",NA,2024-03-21,2024-06-30,Advisory Committees;Award;Clinical;Clinical and Translational Science Awards;Clinical Data;Clinical Research;cloud based;cohort;Collaborations;COVID-19;Data;Data Aggregation;Data Analytics;data de-identification;data enclave;Data Set;Dedications;Development;Environment;Institution;member;National Center for Advancing Translational Sciences;National Institute of General Medical Sciences;Personally Identifiable Information;Persons;privacy protection;programs;Research;Secure;synthetic data;Translational Research;United States National Institutes of Health,SECURE PLATFORMS SUPPORT FOR THE N3C DATA ENCLAVE,0,NA,NA,NA,NA,NA,NA,NA,4685560,NA
11221084,N02,DA,NA,N,NA,NA,NA,NA,75N95022D00025,NA,NA,75N95022D00025-0-759502400002-1,NCATS:47628\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,DENVER,UNITED STATES,NA,01,362130952,US,10065762,"PALANTIR TECHNOLOGIES, INC.",CO,802021866,NA,79942123 (contact),"MARIZAN-HO, JOHANNA  (contact)",NA,2024-08-20,2025-08-17,Advisory Committees;Award;Clinical;Clinical and Translational Science Awards;Clinical Data;Clinical Research;cloud based;cohort;Collaborations;COVID-19;Data;Data Aggregation;Data Analytics;data de-identification;data enclave;Data Set;Dedications;Development;Electronics;Environment;Institution;member;National Center for Advancing Translational Sciences;National Institute of General Medical Sciences;Personally Identifiable Information;Persons;privacy protection;programs;Research;Secure;synthetic data;Translational Research;United States National Institutes of Health,NIDAP ELECTRONIC SCIENTIFIC REVIEW ASSISTANCE (ESRA) APPLICATION SUPPORT,0,NA,NA,NA,NA,NA,NA,NA,47628,NA
11221085,N01,DA,NA,N,NA,NA,NA,NA,271201700020I,NA,NA,271201700020I-P00001-759502200001-1,NCATS:180000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,SAN DIEGO,UNITED STATES,NA,51,079682716,US,3452401,"IRISYS, INC.",CA,921212285,NA,79979743 (contact),"BOURQUE, TIM  (contact)",NA,2022-09-28,2027-07-31,Development;Dosage Forms;manufacture;Phase II Clinical Trials,"THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL",0,NA,NA,NA,NA,NA,NA,NA,180000,NA
11221086,N02,DA,NA,N,NA,NA,NA,NA,75N95024C00025,NA,NA,75N95024C00025-0-9999-1,NCATS:297510\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,BETHESDA,UNITED STATES,NA,NA,NA,US,NA,NA,MD,208172847,NA,79902750 (contact),"BACKUS, MARK  (contact)",NA,2024-07-29,2024-09-18,analytical tool;Award;Businesses;Clinical and Translational Science Awards;Clinical Research;cloud based;cohort;Communities;Complex Analysis;Contracts;COVID-19;cyber security;Data;data enclave;Development;Electronic Health Record;Environment;genetic variant;Genomics;Image;Information Technology;Ingestion;Institution;meetings;multimodal data;National Center for Advancing Translational Sciences;National Institute of General Medical Sciences;open source;Pathology;Privacy;Productivity;programs;Radiology Specialty;Research;Research Personnel;Secure;Security;service programs;Services;synthetic data;tool;Translational Research;United States National Institutes of Health;Viral;virtual;Work,NCATS CYBERSECURITY SERVICES PROGRAM SUPPORT. POP: 07/29/2024 - 09/18/2024.,0,NA,NA,NA,NA,NA,NA,NA,297510,NA
11221089,N02,DA,NA,N,NA,NA,NA,NA,75N95024D00006,NA,NA,75N95024D00006-0-759502400007-1,NCATS:1825925\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NORTH BETHESDA,UNITED STATES,NA,08,020277339,US,10047839,"AXLE INFORMATICS, LLC",MD,208524931,NA,79795274 (contact),"MAYS, GARY  (contact)",NA,2024-05-31,2024-09-30,analytical tool;Area;Award;Clinical and Translational Science Awards;Clinical Research;cloud based;cohort;Collaborations;Communities;Complex Analysis;Contracts;COVID-19;COVID-19 patient;Data;Data Analyses;Data Collection;data enclave;data harmonization;data platform;Data Science;Data Set;Development;Electronic Health Record;Environment;genetic variant;Genomics;Health;Image;Informatics;Information Technology;Ingestion;Institution;meetings;multimodal data;National Center for Advancing Translational Sciences;National Institute of General Medical Sciences;open source;open source tool;Pathology;Privacy;Productivity;programs;protective factors;Pythons;Radiology Specialty;Research;Research Personnel;Risk Factors;Scientist;Secure;Security;Services;Statistical Data Interpretation;synthetic data;tool;Translational Research;United States;United States National Institutes of Health;Viral;virtual;Visualization;Work,TASK ORDER 7 - ODP,0,NA,NA,NA,NA,NA,NA,NA,1825925,NA
11221091,N02,HL,NA,N,NA,NA,NA,NA,75N92022F00181,NA,NA,75N92022F00181-P00008-0-1,OD:6000\,NON SBIR/STTR CONTRACTS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,WASHINGTON,UNITED STATES,NA,NA,NA,US,NA,NA,DC,20007,NA,NA,(contact),NA,2022-07-22,2024-07-21,NA,NHLBI WORKSHOP/CONFERENCE SUPPORT,0,NA,NA,NA,NA,NA,NA,NA,6000,NA
11221094,N01,DA,NA,N,NA,NA,NA,NA,271201700009I,NA,NA,271201700009I-P00005-759502000001-1,NCATS:28500\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,TORRANCE,UNITED STATES,NA,NA,NA,US,NA,NA,CA,905054011,NA,79597307 (contact),"PORTER, KEITH  (contact)",NA,2020-08-04,2024-08-03,Bacterial Artificial Chromosomes;Coenzyme A;Pharmaceutical Preparations;Reference Standards;Testing,HAVE BACHEM ISSUE QA REVIEWED COAS OF GMP DRUG SUBSTANCE PTH-IA AND ITS QUALITATIVE REFERENCE STANDARD AND ASSIGN A NEW RETEST DATE BASED ON THE STABILITY STUDY RESULTS. ANOTHER PURPOSE IS TO HAVE BAC,0,NA,NA,NA,NA,NA,NA,NA,28500,NA
11221096,N02,LM,NA,N,NA,NA,NA,NA,316201200028W,NA,NA,316201200028W-0-759702400001-1,OD:1017637\,NON SBIR/STTR CONTRACTS,2024,NATIONAL LIBRARY OF MEDICINE,NA,FAIRFAX,UNITED STATES,NA,11,072648579,US,1644201,"ICF, INC., LLC",VA,220316050,NA,NA,(contact),NA,2024-09-29,2025-07-28,NA,OFFICE OF COMPUTER AND COMMUNICATIONS SYSTEMS (OCCS) IT TECHNICAL SUPPORT - ICF.,0,NA,NA,NA,NA,NA,NA,NA,1017637,NA
11221097,N02,LM,NA,N,NA,NA,NA,NA,316201300006W,NA,NA,316201300006W-P00021-759702000001-1,OD:1800000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL LIBRARY OF MEDICINE,NA,MCLEAN,UNITED STATES,NA,NA,NA,US,NA,NA,VA,22102,NA,NA,(contact),NA,2020-09-24,2025-09-23,Collaborations;Communication;Computers;Data;Development;Funding;Grant;Information Technology;Infrastructure;Investments;Literature;Phase;Public Health;Research;Services;System;Terminology;tool development;United States National Institutes of Health;United States National Library of Medicine;Women&apos;s Health;Women&apos;s Health Services,INFORMATION TECHNOLOGY SERVICES FOR CONSUMER/PUBLIC HEALTH AND TERMINOLOGY APPLICATIONS FOR THE NATIONAL LIBRARY OF MEDICINE'S (NLM) OFFICE OF COMPUTER AND COMMUNICATIONS SYSTEMS (OCCS),0,NA,NA,NA,NA,NA,NA,NA,1800000,NA
11221098,N02,LM,NA,N,NA,NA,NA,NA,75N97024F00100,NA,NA,75N97024F00100-0-0-1,OD:727620\,NON SBIR/STTR CONTRACTS,2024,NATIONAL LIBRARY OF MEDICINE,NA,LANHAM,UNITED STATES,NA,04,159827104,US,10005037,"SOFTWARE CONSULTANTS, INC.",MD,207064830,NA,NA,(contact),NA,2024-09-20,2025-03-19,NA,TECHNICAL SUPPORT FOR DISCOVERY SERVICE FOR WOMEN'S HEALTH RESEARCH,0,NA,NA,NA,NA,NA,NA,NA,727620,NA
11221101,N02,LM,NA,N,NA,NA,NA,NA,97023A00497024F00002,NA,NA,97023A00497024F00002-0-0-1,OD:1999743\,NON SBIR/STTR CONTRACTS,2024,NATIONAL LIBRARY OF MEDICINE,NA,FAIRFAX,UNITED STATES,NA,11,072648579,US,1644201,"ICF, INC., LLC",VA,220316050,NA,NA,(contact),NA,2024-09-30,2026-03-29,NA,DISCOVER WOMENS HEALTH RESEARCH (DISCOVERWHR) COORDINATION AND CONTENT SUPPORT,0,NA,NA,NA,NA,NA,NA,NA,1999743,NA
11221185,R01,MD,7,N,2024-12-15,2024-12-15,2025-04-30,307,R01MD018253,SCHOOLS OF PUBLIC HEALTH,PA-24-254,7R01MD018253-04,NIMHD:1200559\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,TUCSON,UNITED STATES,PUBLIC HEALTH & PREV MEDICINE,07,806345617,US,490201,UNIVERSITY OF ARIZONA,AZ,857210158,NARRATIVE Colorectal cancer screening among Latinx populations lags far behind that of non-Latinx White populations. We will test a program that pairs video-texting with neighborhood navigation services to improve colorectal cancer screening for adults who are new to screening or have never been screened. Our program could serve as a model for sharing accurate health information and promoting healthy behavior for a variety of diseases.,1953872 (contact);10298216,"CORONADO, GLORIA D (contact);ESCARON, ANNE LAURE","WHITE, DOLLY PENN",2022-09-18,2027-04-30,NA,Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity (PRIME),18253,ZMD1,ZMD1-DRI(A1)R,NA,NA,4,1019064,181495,1200559,NA
11221186,N02,LM,NA,N,NA,NA,NA,NA,97024A00297024F00001,NA,NA,97024A00297024F00001-0-0-1,OD:80000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL LIBRARY OF MEDICINE,NA,ROCKVILLE,UNITED STATES,NA,NA,140697405,US,NA,NA,MD,208506108,NA,80002128 (contact),"MCDOUGALL, ALLIE  (contact)",NA,2024-09-30,2025-09-29,All of Us Research Program;Awareness;community engagement;Community Health Education;Contracts;Libraries;Participant;Positioning Attribute;Precision Medicine Initiative;Program Evaluation;programs;Support Contracts;United States;United States National Institutes of Health;United States National Library of Medicine,USER ENGAGEMENT PROGRAM SUPPORT TASK ORDER,0,NA,NA,NA,NA,NA,NA,NA,80000,NA
11221188,R35,GM,7,N,2024-12-03,2025-01-01,2025-06-30,859,R35GM150481,SCHOOLS OF MEDICINE,PA-24-254,7R35GM150481-03,NIGMS:280562\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,IOWA CITY,UNITED STATES,BIOCHEMISTRY,01,062761671,US,3972901,UNIVERSITY OF IOWA,IA,522421320,"PROJECT NARRATIVE Molecular chaperones maintain protein homeostasis in cells by facilitating protein folding, translocation, and degradation. They exist in multiprotein complexes to regulate cellular processes such as cell signaling, DNA repair, and more recently, cell metabolism. The proposed studies aim to understand how these chaperone complexes recruit and act on metabolic enzymes to meet the increased demand brought on by reprogramming events that contribute to human disease progression.",12213681 (contact),"PEDLEY, ANTHONY M (contact)","PHILLIPS, ANDRE W",2023-07-01,2027-06-30,NA,Molecular Chaperone-mediated Regulated of Cell Metabolism,150481,ZRG1,Special Emphasis Panel[ZRG1-CDB-B(55)R],NA,NA,3,180426,100136,280562,NA
11221193,R44,CA,6,N,2025-01-23,2024-09-03,2025-08-31,393,R44CA236253,NA,PA-24-253,6R44CA236253-04,NCI:343362\,SBIR-STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,MILLBRAE,UNITED STATES,NA,15,NA,US,10084177,FRIENDI.FI CORPORATION,CA,940303118,"Narrative  Delirium, a major cause of falls, can occur in as many as 50% of cancer patients undergoing stem cell transplant,  resulting in up to 14 times greater chance of dying. Delirium risk can be mitigated and many other outcomes of  stem cell transplants can be improved through behavioral interventions delivered at the bedside through  conversation, imagery, and audio. care.coach™ is developing a technology-enabled cancer care platform that  provides 24x7 proactive bedside support for patients undergoing stem cell transplants, to mitigate delirium and  falls while improving recovery through better adherence to diet, exercise, and other best practices, in a scalable,  cost-effective manner.",14986191 (contact),"WANG, VICTOR  (contact)","WEBER, PATRICIA A",2019-04-05,2026-08-31,NA,A Bedside Relational Agent to Improve Hematopoietic Cell Transplantation Outcomes in Cancer Patients,236253,ZRG1,Special Emphasis Panel[ZRG1-RPHB-Z(10)B],NA,NA,4,237703,83196,343362,NA
11221348,R01,HS,7,N,2024-11-12,2024-10-01,2025-02-28,226,R01HS029319,NA,PA-22-047,7R01HS029319-03,AHRQ:3853\,NON-SBIR/STTR RPGS,2024,AGENCY FOR HEALTHCARE RESEARCH AND QUALITY,NA,BOSTON,UNITED STATES,NA,08,073130411,US,4907701,MASSACHUSETTS GENERAL HOSPITAL,MA,021142621,"Project Narrative More than 9 in 10 individuals carrying a penicillin allergy label are not truly allergic, which has widespread consequences that include a higher risk of antibiotic-resistant bacteria. Removal of inaccurate penicillin allergy labels (de-labeling) is a safe and recommended strategy to improve antibiotic prescribing. This project seeks to measure, understand, and improve equitable access to penicillin allergy de-labeling.",12253299 (contact);11409197,"BLUMENTHAL, KIMBERLY GOLD (contact);WURCEL, ALYSSE GAIL","LIN, LEYI",2023-05-01,2028-02-29,NA,Improving Equitable Access to Penicillin Allergy De-Labeling,29319,HSQR,Healthcare Patient Safety and Quality Improvement Research[HSQR],NA,NA,3,2307,1546,3853,NA
11221905,P20,GM,5,N,2024-02-23,2024-10-03,2025-01-31,NA,P20GM130457,NA,PAR-18-266,5P20GM130457-05,NIGMS:224250\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,CHARLESTON,UNITED STATES,NA,06,183710748,US,7575301,MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,294074636,NA,11937199 (contact),"STANCILL, JENNIFER SUSAN (contact)","KOVBASNJUK, OLGA NIKOLAEVNA",2024-10-03,2025-01-31,NA,Peroxiredoxin 1 in pancreatic beta-cells,130457,ZGM1,ZGM1-RCB-3(C1),5597,NA,5,150000,74250,NA,224250
11221969,R37,CA,7,N,2025-01-21,2024-09-01,2025-08-31,396,R37CA258730,SCHOOLS OF MEDICINE,PA-24-254,7R37CA258730-05,NCI:467016\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,NEW HAVEN,UNITED STATES,UROLOGY,03,043207562,US,9420201,YALE UNIVERSITY,CT,065208327,"PROJECT NARRATIVE The resistance to current AR targeted therapies is one of the biggest challenges when treating advanced prostate cancer and largely hinders the clinical outcome of patients with this deadly disease. This study aims to determine the molecular role of a new potential tumor suppressor in prostate cancer, SYNCRIP, in suppressing APOBEC- mediating mutagenesis and resistance to AR targeted therapies. Elucidating the role of this protein and the molecular mechanism of the resistance may identify new actionable targets and establish a pathway for the development of therapeutic approaches to overcome the resistance and ultimately benefit patients.",14536041 (contact),"MU, PING  (contact)","KAI, MIHOKO",2021-05-01,2026-08-31,advanced prostate cancer;Affect;American;androgen independent prostate cancer;apoB mRNA editing catalytic subunit;Apoptosis;Automobile Driving;Binding;cancer diagnosis;cancer initiation;Cancer Patient;Castration;Cell Proliferation;Cells;Clinical;Cytoplasm;Data;Deaminase;Dependence;Disease;DNA;DNA Sequence Alteration;enzalutamide;Genes;genetic testing;Genetically Engineered Mouse;Genomics;Human;Impairment;improved;In Vitro;in vitro Model;in vivo;insight;knock-down;Knock-out;Libraries;Malignant neoplasm of prostate;Mediating;men;Messenger RNA;Molecular;mouse model;Mus;Mutagenesis;Mutate;neoplastic cell;novel;Oncogenes;Oncogenic;Organoids;Outcome;Pathologic;Pathway interactions;Patient-Focused Outcomes;Patients;Pattern;prostate cancer cell;prostate cancer cell line;prostate cancer model;Proteins;Reporting;Resistance;resistance mechanism;Resolution;response;RNA-Protein Interaction;Role;screening;senescence;Signal Pathway;synaptotagmin;targeted treatment;therapeutic development;therapeutic target;therapy resistant;treatment response;tumor;tumor growth;tumor heterogeneity;Tumor Suppressor Genes;Tumor Suppressor Proteins;tumorigenesis;Work;Xenograft Model,Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance,258730,MCT2,Mechanisms of Cancer Therapeutics - 2 Study Section[MCT2],NA,NA,5,288587,178429,467016,NA
11222010,R01,AI,7,N,2024-11-21,2024-11-01,2025-11-30,855,R01AI150214,SCHOOLS OF DENTISTRY/ORAL HYGN,PA-24-254,7R01AI150214-06,NIAID:323830\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,BALTIMORE,UNITED STATES,DENTISTRY,07,188435911,US,820104,UNIVERSITY OF MARYLAND BALTIMORE,MD,212011508,"PROJECT NARRATIVE Host innate immune response plays a crucial role in combating a large number of viral infections. This proposal focuses on the protein OAS1, which is produced during the early part of the host response and helps shape the later adaptive response to clear viral infections. We have discovered that the OAS1 protein uniquely controls the host immune response to virus infections, including against flaviviruses such as West Nile virus. When completed, our studies should create a new paradigm for understanding how OAS1 functions to inhibit viruses.",6190835;8653358 (contact),"DIAMOND, MICHAEL S;SARKAR, SAUMENDRA N (contact)","LIU, QIAN",2019-12-20,2025-11-30,3&apos; Splice Site;adaptive immune response;adaptive immunity;Affect;Alleles;Alternative Splicing;Anti-viral resistance;antiviral drug development;Automobile Driving;Binding;Biochemical;Biological Assay;C-terminal;cell type;Cells;Cellular biology;cellular targeting;Code;Data;Diamond;DNA Viruses;Event;experimental study;Family;Family member;Flavivirus;Genes;Genetic Polymorphism;Goals;Grant;Hematopoietic;Host Defense;Human;Human Genome;Immune response;In Vitro;in vivo;Infection;Innate Immune Response;Interferon Type I;Interferons;IRF1 gene;Knock-in Mouse;knockout gene;Knowledge;Laboratories;Laboratory mice;Length;Ligase;loss of function;Maps;Mediating;Mediator;member;Messenger RNA;Molecular;mouse genome;Mus;Mutate;Natural Immunity;Nature;Nucleic Acids;oligoadenylate;Organ;Orthologous Gene;Play;Predisposition;promoter;Property;protein expression;Protein Family;Protein Isoforms;Protein Synthesis Inhibition;Protein Truncation;Proteins;Proteomics;Reporter;response;Ribonucleases;RNA immunoprecipitation sequencing;RNA Viruses;Role;Scheme;Severity of illness;Shapes;Signal Transduction;Site;T-Lymphocyte;Terminator Codon;Testing;Therapeutic;Transferase;Translational Regulation;Translations;Untranslated Regions;Up-Regulation;Vaccinia virus;Viral;Viral Pathogenesis;Viral Physiology;Viral Proteins;Virus;Virus Diseases;Virus Replication;West Nile viral infection;West Nile virus,A new mechanism of antiviral activity of 2-5 Oligoadenylate Synthetase 1,150214,III,Innate Immunity and Inflammation Study Section[III],NA,NA,6,208251,115579,323830,NA
11222203,K08,AI,7,N,2024-11-29,2024-11-01,2025-05-31,855,K08AI180362,SCHOOLS OF MEDICINE,PA-24-254,7K08AI180362-02,NIAID:177404\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,DALLAS,UNITED STATES,INTERNAL MEDICINE/MEDICINE,30,800771545,US,578404,UT SOUTHWESTERN MEDICAL CENTER,TX,753909105,"Project Narrative  Patients who have received joint replacement are at risk for periprosthetic joint infection, a serious condition which can lead to morbidity, disability, amputation, and even death. We will investigate how an injectable biomaterials-based vaccine system improves host immunity to prevent Staphylococcus aureus periprosthetic joint infection in a murine model. This project will lead to a better understanding of immunity in device-related infection and characterize a new vaccine modality.",12308427 (contact),"TATARA, ALEXANDER MITCHELL (contact)","ZOU, LANLING",2024-06-14,2029-05-31,NA,Biomaterials-based Immunoengineering for Periprosthetic Joint Infection,180362,MID,Microbiology and Infectious Diseases Advisory Committee[MID],NA,NA,2,164263,13141,177404,NA
11222245,P20,GM,5,N,2023-12-20,2024-01-01,2024-12-31,NA,P20GM121327,NA,PAR-19-312,5P20GM121327-08,NIGMS:110914\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,LEXINGTON,UNITED STATES,NA,06,939017877,US,2793601,UNIVERSITY OF KENTUCKY,KY,405260001,NA,11465648 (contact),"MOHRIN, MARY  (contact)","GARTRELL, KYUNGSOOK",2024-10-31,2026-12-31,Acute Myelocytic Leukemia;Age;age-related disease;aged;Aging;biological adaptation to stress;Cancer Center;Cardiovascular Diseases;Cells;Cellular Stress;Chronology;Clone Cells;Defect;Disease;Fatty Liver;Hematopoiesis;Hematopoietic stem cells;Hematopoietic System;Human;Immune;Immunologic Surveillance;Infiltration;Kentucky;Knockout Mice;Longevity;Mitochondria;Myelogenous;Myocardial dysfunction;Pathway interactions;Peripheral;Preleukemia;Quality Control;Regulation;residence;response;Risk;Tissues;Touch sensation;tumor metabolism;Universities,Targeting SIRT7 Regulation of Mitochondrial Quality Control to Short Circuit Age-Related Diseases of the Hematopoietic System,121327,ZGM1,ZGM1-RCB-3(C2),5644,NA,8,72493,38421,NA,110914
11222311,P20,GM,5,N,2024-09-18,2024-10-28,2025-07-31,NA,P20GM113126,NA,PAR-19-312,5P20GM113126-09,NIGMS:164138\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,LINCOLN,UNITED STATES,NA,01,555456995,US,578103,UNIVERSITY OF NEBRASKA LINCOLN,NE,685032427,NA,12077665 (contact),"TANG, QING  (contact)","CUPIT, PAULINE",2024-10-28,2026-07-31,Actin-Binding Protein;Actins;Active Biological Transport;Architecture;Binding;Biogenesis;cancer cell;Cell Communication;Cells;Cellular biology;Cellular Structures;cofilin;Communication;Crosslinker;Cytoskeleton;density;Disease;F-Actin;fascin;Filament;Goals;Human;Human Pathology;Immune;Impairment;innovation;intercellular communication;Intervention;Ions;Maintenance;Maps;Membrane;Methods;Microfilaments;Microscopy;Mitochondria;Modeling;Molecular;Molecular Biology;Molecular Motors;Morphogenesis;Movement;Myosin ATPase;Myosin Type V;Nanotubes;Nebraska;Organelles;Pathology;Pathway interactions;pharmacologic;Physiology;Population;predictive modeling;Process;protein aggregation;Protein Chemistry;Proteins;Role;Side;Signal Transduction;single molecule;small molecule;spatiotemporal;stem;Structure;superresolution microscopy;System;Technology;Testing;Theft;Therapeutic;Thinness;Tropomyosin;Tube;ultra high resolution;vasodilator-stimulated phosphoprotein;Vesicle;Virus,Mechanisms of tunneling nanotube architecture and function,113126,ZGM1,ZGM1-RCB-3(C2),5645,NA,9,105263,58875,NA,164138
11222331,R01,AI,7,N,2024-12-26,2024-12-01,2025-05-31,855,R01AI185041,SCHOOLS OF MEDICINE,PA-24-254,7R01AI185041-02,NIAID:565013\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NEW ORLEANS,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,01,053785812,US,8424601,TULANE UNIVERSITY OF LOUISIANA,LA,701185665,"PROJECT NARRATIVE The goal of these studies is to understand how sensory nerves in the skin regulate immune cell function during skin penetration by parasitic worms found in contaminated water. We think that protective immunity against these worms may be dependent on interactions between itch-specific nerves and immune cells in the skin, but this has not been studied before. The proposed experiments may uncover a therapeutic means to prevent skin penetration, which does not currently exist.",1952014 (contact),"HERBERT, DE'BROSKI R (contact)","PESCE, JOHN T",2024-07-05,2029-05-31,NA,Neuro-Immune mechanisms against skin-penetrating helminths,185041,ZRG1,Special Emphasis Panel[ZRG1-IIDA-F(09)F],NA,NA,2,395976,169037,565013,NA
11222335,R21,DC,7,N,2024-12-04,2024-09-01,2024-11-30,173,R21DC019409,SCHOOLS OF ARTS AND SCIENCES,PAR-21-107,7R21DC019409-04,NIDCD:127282\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,ANN ARBOR,UNITED STATES,PSYCHOLOGY,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,PROJECT NARRATIVE Frequency modulations are crucial to our ability to communicate via speech and music. This research will provide insights into how frequency modulation is represented in the normal-hearing human auditory system across the adult lifespan. These findings will be an important first step towards revealing how the coding of frequency modulation changes with both age and hearing loss and will help guide future interventions to improve communications for people with hearing difficulties.,14257266 (contact),"WHITEFORD, KELLY L (contact)","KING, KELLY ANNE",2021-12-01,2024-11-30,Acoustics;Adult;Affect;Age;age effect;Auditory system;Behavior assessment;behavior measurement;Behavioral;Characteristics;Clinical;Cochlea;Cochlear Implants;Code;Communication;Complex;Computer Models;Computing Methodologies;Cues;Data;design;Detection;Electroencephalography;experimental study;Foundations;Frequencies;Future;Goals;Grain;Hearing Aids;hearing impairment;Human;improved;Individual;insight;Intervention;life span;Measures;Mechanics;Modeling;Music;neural;noise perception;normal aging;normal hearing;novel;older adult;Output;Pattern;Perception;Performance;Peripheral;Persons;Phase;Physiological;Play;Process;Psychoacoustics;Research;response;Role;Sampling;segregation;Sensory;Signal Detection Analysis;skills;sound;Speech;speech in noise;stem;Stimulus;Structure;Testing;theories;Time;trend;usability,Neural and Perceptual Mechanisms for Coding Frequency Modulation,19409,CDRC,Communication Disorders Review Committee[CDRC],NA,NA,4,81591,45691,127282,NA
11222446,N01,DA,NA,N,NA,NA,NA,NA,75N95024C00027,NA,NA,75N95024C00027-0-9999-1,NIMH:1850908\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,SAINT LOUIS,UNITED STATES,NA,01,068552207,US,9083901,WASHINGTON UNIVERSITY,MO,631304862,NA,1952879 (contact),"ANCES, BEAU M (contact)",NA,2024-09-23,2025-09-22,Aging;Autopsy;Biological;Clinical Data;clinical research site;Contracts;Ensure;Geography;HIV;HIV Seronegativity;Midwestern United States;neuroAIDS;Neuropathogenesis;Organ Donor;Persons;Research;Research Priority;Resources;Specimen;Tissues;United States National Institutes of Health;volunteer,THE NIH NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - NEW CLINICAL SITE,0,NA,NA,NA,NA,NA,NA,NA,1850908,NA
11222462,N01,DA,NA,N,NA,NA,NA,NA,75N95024C00033,NA,NA,75N95024C00033-0-9999-1,NIMH:300000\,NON SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,PEARLAND,UNITED STATES,NA,22,078474555,US,10033420,"BASE PAIR BIOTECHNOLOGIES, INC.",TX,775849775,NA,14727018 (contact),"JACKSON, GEORGE W (contact)",NA,2024-09-15,2025-09-14,Adherence;Contracts;Development;HIV;Measures;Phase;Small Business Innovation Research Grant;Tenofovir;Treatment Protocols,APTASENSORS FOR MEASURING LONG TERM ADHERENCE TO TENOFOVIR-BASED AND LONG ACTING HIV TREATMENT REGIMENS,0,NA,NA,NA,NA,NA,NA,NA,300000,NA
11222472,N43,DA,NA,N,NA,NA,NA,NA,75N95024C00040,NA,NA,75N95024C00040-0-9999-1,NIMH:299999\,SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,ELLICOTT CITY,UNITED STATES,NA,03,117513249,US,10061484,"VITRUVIAN BIO, LLC",MD,210433457,NA,79992070 (contact),"SENPEN, ANGANA  (contact)",NA,2024-09-23,2025-09-22,Adherence;Biological Assay;Contracts;Development;Devices;HIV;HIV Infections;medication compliance;Monitor;monitoring device;National Institute of Mental Health;Pharmaceutical Preparations;pharmacologic;Phase;Physicians;point of care;prototype;sensor;Small Business Innovation Research Grant;Therapeutic;Viral Load result;Virus Integration,NIMH SBIR PHASE 1 TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS,0,NA,NA,NA,NA,NA,NA,NA,299999,NA
11222473,N43,DA,NA,N,NA,NA,NA,NA,75N95024C00036,NA,NA,75N95024C00036-0-9999-1,NIMH:299976\,SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,CHELMSFORD,UNITED STATES,NA,03,796010411,US,4327301,"TRITON SYSTEMS, INC.",MA,018244053,NA,78914431 (contact),"BAI, JING  (contact)",NA,2024-09-23,2025-09-22,3-Dimensional;analog;blood-brain barrier permeabilization;Coculture Techniques;Communication;Contracts;Development;Gene Expression;In Vitro;in vivo Model;National Institute of Mental Health;neuroAIDS;Neuroimmune;neuroinflammation;Neurons;Neurosphere;novel;Phase;Research;Small Business Innovation Research Grant;System;Tissues;Triton;United States National Institutes of Health,SBIR PHASE 1 (NIH/NIMH TOPIC 002 - DEVELOPMENT OF NOVEL IN-VITRO AND IN-VIVO MODELS TO SUPPORT NEUROHIV RESEARCH)TRITON SYSTEMS INC:1185597 [24-001257],0,NA,NA,NA,NA,NA,NA,NA,299976,NA
11222476,N43,DA,NA,N,NA,NA,NA,NA,75N95024C00035,NA,NA,75N95024C00035-0-9999-1,NIMH:50000\,SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,SAN DIEGO,UNITED STATES,NA,51,612181532,US,4087401,"VALA SCIENCES, INC.",CA,921213225,NA,1882226 (contact),"MCDONOUGH, PATRICK M (contact)",NA,2024-09-27,2025-09-26,Astrocytes;Biological Assay;Biological Models;Brain;Cells;Contracts;Development;HIV;Human;human induced pluripotent stem cells;In Vitro;in vitro Model;in vivo Model;Microglia;National Institute of Mental Health;neuroAIDS;neurotoxicity;novel;Phase;Research;Science;Small Business Innovation Research Grant;System;Testing;Therapeutic;United States National Institutes of Health,SBIR PHASE 1 (NIH/NIMH TOPIC 002 - DEVELOPMENT OF NOVEL IN-VITRO AND IN-VIVO MODELS TO SUPPORT NEUROHIV RESEARCH) VALA SCIENCES INC.:1165050 [24-004928],0,NA,NA,NA,NA,NA,NA,NA,50000,NA
11222478,N43,DA,NA,N,NA,NA,NA,NA,75N95024C00026,NA,NA,75N95024C00026-0-9999-1,NIMH:299976\,SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,DUBLIN,UNITED STATES,NA,15,001004258,US,1698201,"GUILD ASSOCIATES, INC.",OH,430161234,NA,10515161 (contact),"SMIECHOWSKI, MATTHEW FRANCIS (contact)",NA,2024-09-09,2025-09-08,Adherence;Biological Assay;Contracts;Development;Devices;HIV;HIV Infections;medication compliance;Monitor;monitoring device;National Institute of Mental Health;Pharmaceutical Preparations;pharmacologic;Phase;Physicians;point of care;prototype;sensor;Small Business Innovation Research Grant;Therapeutic;Viral Load result;Virus Integration,NIMH SBIR PHASE I  TOPIC 001-  POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS,0,NA,NA,NA,NA,NA,NA,NA,299976,NA
11222488,N43,DA,NA,N,NA,NA,NA,NA,75N95024C00030,NA,NA,75N95024C00030-0-9999-1,NIMH:306499\,SBIR/STTR CONTRACTS,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,NEWTON,UNITED STATES,NA,04,066594979,US,1379901,"GINER, INC.",MA,024661311,NA,79983746 (contact),"RANA, MUHIT  (contact)",NA,2024-09-16,2025-09-15,Adherence;Biological Assay;Contracts;Development;Devices;HIV;HIV Infections;medication compliance;Monitor;monitoring device;National Institute of Mental Health;Pharmaceutical Preparations;pharmacologic;Phase;Physicians;point of care;prototype;sensor;Small Business Innovation Research Grant;Therapeutic;Viral Load result;Virus Integration,NIMH SBIR PHASE I TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS,0,NA,NA,NA,NA,NA,NA,NA,306499,NA
11222564,R01,AA,7,N,2024-12-27,2024-11-01,2025-03-31,273,R01AA029137,GRADUATE SCHOOLS,PA-24-254,7R01AA029137-05,NIAAA:643399\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,BERKELEY,UNITED STATES,PSYCHOLOGY,12,124726725,US,577502,UNIVERSITY OF CALIFORNIA BERKELEY,CA,947101749,"Project Narrative Heavy drinking in young adults is associated with serious negative consequences and is a major public health concern; however, interventions have shown limited efficacy. The goal of this project is to evaluate cognitive- based and mindfulness-based Regulation of Craving Training (ROC-T), which are novel, brief, web-based interventions that directly target core mechanisms implicated in drinking: craving and the regulation of craving. We specifically propose a randomized-controlled trial comparing these interventions to a control condition, and to test the effects on drinking as well as on cognitive, affective, and neural mechanisms.",9550425 (contact),"KOBER, HEDY  (contact)","MATOCHIK, JOHN A",2024-11-01,2026-03-31,NA,Regulation of Craving: Clinical Trial and Neural Mechanisms,29137,NPAS,"Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section[NPAS]",NA,NA,5,426355,217044,643399,NA
11222775,P20,GM,5,N,2024-10-30,2024-11-01,2025-07-31,NA,P20GM125498,NA,PAR-22-163,5P20GM125498-07,NIGMS:160084\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,BURLINGTON,UNITED STATES,NA,00,066811191,US,8738101,UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,054051704,"Epstein-Barr virus (EBV) is an oncogenic virus that plays a pervasive role in the pathogenesis of diffuse  large B-cell lymphoma (DLBCL), causing clinically aggressive disease across disparate immunodeficiency  settings of global patient populations. This project aims to comprehensively characterize the genomic  profiles of EBV(+) DLBCL arising in immunodeficiency settings of sub-Saharan Africa and the United  States to identify diagnostic and prognostic biomarkers and ultimately improve clinical outcomes.",79605521 (contact),"VOLARIC, ASHLEY  (contact)","GARTRELL, KYUNGSOOK",2024-11-01,2028-07-31,Advisory Committees;Africa South of the Sahara;Aggressive behavior;biobank;Bioinformatics;Biological;Biology;Biometry;burden of illness;Categories;Centers of Research Excellence;Clinical;clinically significant;cohort;computerized data processing;Data Analyses;Development;Diagnosis;Diagnostic;diagnostic biomarker;Disease;Disparate;Epstein-Barr pathogenesis;genomic profiles;Genomics;global health;Goals;HIV;Human Herpesvirus 4;Iatrogenesis;immunodeficiency;improved;Infectious Diseases Research;Knowledge;large cell Diffuse non-Hodgkin&apos;s lymphoma;Leadership;Lymphoma;Lymphomagenesis;Mediating;Mentors;Mentorship;Molecular Profiling;multiple omics;multiplexed imaging;Oncogenic Viruses;Outcome;Outcome Study;Pathogenesis;Pathogenicity;Pathologic;patient population;Patients;Play;Population;Positioning Attribute;Prognostic Marker;programs;Research;Role;skills;targeted treatment;therapeutic target;United States;viral RNA;Virus Latency,EBV-Positive Diffuse Large B-cell Lymphoma: Defining Biologic Determinants of Disease Pathogenesis in Immunodeficiency,125498,ZGM1,ZGM1-RCB-4(C2),5671,NA,7,104652,55432,NA,160084
11223084,R01,GM,7,N,2024-12-20,2024-09-01,2025-06-30,859,R01GM151093,SCHOOLS OF ARTS AND SCIENCES,PA-24-254,7R01GM151093-03,NIGMS:254244\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,ATLANTA,UNITED STATES,CHEMISTRY,05,066469933,US,2384501,EMORY UNIVERSITY,GA,303221007,"Raman microscopy grants important advantages over other more common optical techniques, offering expanded multiplexing capabilities for simultaneous visualization of large numbers of distinct biomolecules and structures with high spatiotemporal resolution. This research project focuses on the development of next-generation Stimulated Raman Scattering (SRS) responsive molecular probes to be implemented with complementary SRS microscopy instrumentation to enable high-speed, super-multiplexed visualization of transient molecular species and dynamic processes in live cells",11362403 (contact),"BUCCELLA, DANIELA  (contact)","YEH, ALVIN TIEN-WEI",2023-09-21,2027-06-30,NA,Super-Multiplexed Molecular Sensing in Live Cells,151093,ZRG1,Special Emphasis Panel[ZRG1-MCST-J(02)M],NA,NA,3,170979,83265,254244,NA
11223128,K01,DA,7,N,2024-12-12,2024-09-14,2025-08-31,279,K01DA057414,SCHOOLS OF MEDICINE,PA-24-254,7K01DA057414-03,NIDA:164353\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,DETROIT,UNITED STATES,NONE,13,001962224,US,9110501,WAYNE STATE UNIVERSITY,MI,482024000,"Project Narrative  As the overdose crisis continues, some local prosecutors have increased their use of criminal legal penalties to address overdose deaths—despite evidence suggesting that doing so worsens public health outcomes for people who use drugs and their communities. Using a legal epidemiological framework, this study analyzes (1) the factors that influence prosecutors’ decisions to treat an overdose as a murder instead of a public health issue, (2) how such charges impact the health of people at risk of overdose, and (3) how investment in local public health efforts can decrease the involvement of the criminal justice system in addressing overdose deaths.",16282250 (contact),"EL-SABAWI, TALEED  (contact)","MULFORD, CARRIE FRIED",2023-09-30,2028-08-31,NA,The Influence of Public Health Infrastructure on Prosecutorial Responses to the Opioid Crisis,57414,CIHB,Community Influences on Health Behavior Study Section[CIHB],NA,NA,3,152179,12174,164353,NA
11223358,Z01,CL,1,N,NA,NA,NA,NA,Z01CL900002,NA,NA,1Z01CL900002-23,NA,INTRAMURAL RESEARCH,2024,CLINICAL CENTER,NA,NA,NA,NA,NA,NA,NA,NA,CLINICAL CENTER,NA,NA,NA,14182392 (contact),"MANAGEMENT, INCLUSION  (contact)",NA,NA,NA,NA,HSCT CLC,900002,NA,NA,NA,NA,23,NA,NA,NA,NA
11223557,R01,AI,7,N,2024-12-23,2024-12-01,2025-07-31,855,R01AI164715,SCHOOLS OF MEDICINE,PA-24-254,7R01AI164715-05,NIAID:243913\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,NEW ORLEANS,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,01,053785812,US,8424601,TULANE UNIVERSITY OF LOUISIANA,LA,701185665,"Project narrative Interleukin 33 (IL-33) is a unique member of the IL-1 superfamily of cytokines that regulate innate and adaptive immunity against gastrointestinal pathogens. IL-33 serves as both a pro- and anti-inflammatory mediator of host protective immunity, but the mechanisms responsible remain unclear. This project will investigate the hypothesis that cellular source of IL-33 is a critical determinant in host protective immunity against helminth and protozoan pathogens.",1952014 (contact),"HERBERT, DE'BROSKI R (contact)","PESCE, JOHN T",2021-08-06,2025-07-31,NA,Myeloid derived IL-33 controls Treg responses during parasite infection,164715,IHD,Immunity and Host Defense Study Section[IHD],NA,NA,5,159420,84493,243913,NA
11224506,K08,DK,7,N,2024-12-19,2024-12-19,2025-04-30,847,K08DK133639,NA,PA-24-254,7K08DK133639-03,NIDDK:145513\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,PHILADELPHIA,UNITED STATES,NA,03,073757627,US,1499101,CHILDREN'S HOSP OF PHILADELPHIA,PA,191462305,"PROJECT NARRATIVE  The proposed research is relevant to public health because it will define mechanistically how a risk factor for obesity regulates host metabolism through the microbiota. The research will also enhance our understanding of Intelectin-1 on metabolic syndrome and the translational implications of Intelectin-1 interaction with the microbi- ota in early life weight gain and childhood obesity. The proposed studies are relevant to the mission of the NIDDK as our studies are expected to identify new insights into factors associated with metabolic syndrome and eluci- date potential mechanisms and, thus, therapeutic strategies for preventing obesity starting in infancy.",14125563 (contact),"MATUTE, JUAN D. (contact)","SASLOWSKY, DAVID E",2023-07-01,2027-04-30,NA,Intestinal Intelectin-1 regulation of obesity development,133639,DDK,Digestive Diseases and Nutrition C Study Section[DDK-C],NA,NA,3,134734,10779,145513,NA
11224571,K23,DA,7,N,2024-12-23,2024-11-01,2025-03-31,279,K23DA053989,SCHOOLS OF MEDICINE,PA-24-254,7K23DA053989-05,NIDA:180000\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,CHICAGO,UNITED STATES,INTERNAL MEDICINE/MEDICINE,05,005436803,US,6144650,NORTHWESTERN UNIVERSITY AT CHICAGO,IL,606114579,"Project Narrative Despite clear evidence of the benefit of integrated care for HIV and opioid use disorder on both HIV and opioid use disorder related outcomes, there is a gap between the evidence and “real- world” practices. The objectives of this proposal are to understand the barriers to integrated care from the patient, provider, clinic, and governmental level in New Jersey and to evaluate the effectiveness of an implementation strategy, that uses coaching and a collaborative learning environment, to help clinics adopt an integrated care model for HIV and opioid use disorder treatment. It is expected that the findings from this project will contribute valuable information about the impact and mechanisms by which implementation science strategies improve the quality of health care delivery to people with HIV and opioid use disorder.",12366285 (contact),"NYAKU, AMESIKA  (contact)","WEBB, CANDACE KARONDELETTE",2021-04-01,2026-03-31,NA,Implementing Integrated Services for People With HIV and Opioid Use Disorder,53989,PPAH,Population and Public Health Approaches to HIV/AIDS Study Section[PPAH],NA,NA,5,166666,13334,180000,NA
11224812,R01,AI,7,N,2024-12-04,2024-11-01,2025-01-31,855,R01AI140303,SCHOOLS OF MEDICINE,PA-24-254,7R01AI140303-06,NIAID:400917\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,GALVESTON,UNITED STATES,INTERNAL MEDICINE/MEDICINE,14,800771149,US,578406,UNIVERSITY OF TEXAS MED BR GALVESTON,TX,775555302,"Unfortunately, it is challenging to achieve and maintain adequate immunosuppression over time for kidney transplant patients due to variation in the blood levels of immunosuppressive medications. This study will determine if variations in the microbes in the stool are associated with blood levels of immunosuppressive medication named mycophenolate mofetil. We will also determine if variations in the microbes in the human body lead to higher blood levels of this medication and thereby explain the side effects of this medication seen commonly in kidney transplant patients.",10396266;1953365 (contact);6523999;15369139,"GUAN, WEIHUA ;ISRANI, AJAY K (contact);JACOBSON, PAMALA A;STALEY, CHRISTOPHER","ODIM, JONAH",2019-02-01,2025-01-31,absorption;Accounting;Acute;allograft rejection;Anemia;Antibiotics;Area Under Curve;Bacteroides;Beta-glucuronidase;Biliary;Blood;Clinical;Clostridium perfringens;cohort;Diarrhea;Diet;Dose;drug disposition;Drug Kinetics;Enrollment;Escherichia coli;Excretory function;experience;Exposure to;fecal microbiome;fecal transplantation;Feces;fungus;Future;Genes;Genetic Transcription;genetic variant;Glomerular Filtration Rate;Glucuronides;Goals;gut bacteria;gut microbes;gut microbiome;gut microbiota;Hematology;Hour;Human body;Hydrolysis;Immune;Immunosuppression;Immunosuppressive Agents;improved;innovation;inter-individual variation;Investigation;Kidney;kidney allograft;Kidney Transplantation;Lead;Leukopenia;Measures;metatranscriptomics;Methods;Microbe;microbial;microbiome;microbiome composition;microbiome research;microbiota;microbiota profiles;Modeling;multidisciplinary;mycophenolate mofetil;Mycophenolic Acid;Names;Oral;Outcome;Patient-Focused Outcomes;Patients;Pattern;Pharmaceutical Preparations;Pilot Projects;Plasma;Population;predictive test;prospective;Prospective cohort;Randomized;Recycling;Ruminococcus;Sampling;Shotgun Sequencing;side effect;Streptococcus Group B;Tacrolimus;Text Messaging;Time;Toxic effect;transcriptome sequencing;Transplant Recipients;Transplantation;Variant;Work,Gut Microbiota and Effect on Immune Suppressants in Transplantation,140303,XNDA,Xenobiotic and Nutrient Disposition and Action Study Section[XNDA],NA,NA,6,280398,120519,400917,NA
11224948,R01,NS,7,N,2024-11-21,2024-11-04,2025-02-28,853,R01NS122394,NA,PA-24-254,7R01NS122394-05,NINDS:224816\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,MEMPHIS,UNITED STATES,NA,09,067717892,US,7893501,ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,381053678,"Narrative The binding of glutamate to metabotropic glutamate receptors (mGluRs) and of g-aminobutyric acid (GABA) to GABAB receptors drives signaling cascades that start with G protein binding to the intracellular side of the receptor. We propose to obtain the cryo-electron microscopy (cryo-EM) structures of mGluR2, mGluR5 and GABAB receptor in complex with their G protein partners and interrogate the signaling mechanism with in vitro assays and molecular dynamics (MD) simulations. As defects in glutamatergic and GABAergic signaling are linked to many neurological conditions such as Parkinson's disease, schizophrenia, drug addiction, depression, and pain, this knowledge will be ultimately used for the design of novel therapeutic strategies to combat these disorders.",9763164 (contact),"SKINIOTIS, GEORGIOS  (contact)","UMANAH, GEORGE KWABENA ESSIEN",2024-11-04,2026-02-28,NA,Structural Basis of Signal Instigation Through Family C GPCRs,122394,ZRG1,Special Emphasis Panel[ZRG1-CB-C(02)M],NA,NA,5,121522,103294,224816,NA
11224955,R01,DK,7,N,2025-01-11,2025-01-11,2025-03-31,847,R01DK132902,NA,PA-24-254,7R01DK132902-04,NIDDK:317220\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,MEMPHIS,UNITED STATES,NA,09,067717892,US,7893501,ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,381053678,"Narrative Calcium is the most abundant mineral in the human body and its levels are maintained with the help of the extracellular calcium-sensing receptor (CaSR), a cell membrane protein. Genetic and functional defects in CaSR result in diverse diseases related to calcium metabolism: overactive CaSR leads to low blood calcium level (hypocalcemia) that causes muscle cramping and seizures; whereas underactive CaSR results in high blood calcium level (hypercalcemia), hyperactive parathyroid glands (hyperparathyroidism), kidney stones and various neurological disorders. This work will fill the gap in our structural and mechanistic understanding of CaSR function and regulation that are key to human health, and provide insights into the design of new drugs that will alleviate the CaSR associated medical conditions.",9763164 (contact),"SKINIOTIS, GEORGIOS  (contact)","SECHI, SALVATORE",2022-04-01,2027-03-31,NA,Mechanistic Basis of Calcium Sensing Receptor Signaling,132902,ZRG1,Special Emphasis Panel[ZRG1-CB-F(02)M],NA,NA,4,171470,145750,317220,NA
11225243,R01,AI,7,N,2024-11-25,2024-12-01,2025-02-28,855,R01AI149766,SCHOOLS OF MEDICINE,PA-24-254,7R01AI149766-06,NIAID:149294\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,AMHERST,UNITED STATES,NONE,26,038633251,US,5992614,STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,142282567,"Project narrative The parasite Toxoplasma gondii infects nearly a third of the word population and can lead to severe disease and even death in immunocompromised individuals and those infected congenitally. This parasite possesses a single mitochondrion that is essential for its survival and interestingly changes shape as the parasite goes from cell to cell. Our research aims at identifying the proteins and processes that control the shape of the mitochondrion, which will reveal new ways to target the mitochondrion as a way to combat toxoplasmosis.",1896436 (contact),"ARRIZABALAGA, GUSTAVO A (contact)","MCGUGAN, GLEN C",2020-03-03,2025-02-28,Address;Affect;Amino Acids;Apical;Apicomplexa;Automobile Driving;Auxins;Biochemistry;Biological Assay;Biology;Biotinylation;Calcium;Cells;Cessation of life;Co-Immunoprecipitations;combat;Complex;Coupling;Cytokinesis;daughter cell;Development;Disease;domain mapping;Drug Targeting;Economic Burden;Environment;experimental study;extracellular;Health;Homeostasis;human pathogen;Image;Immunocompromised Host;In Vitro;in vivo;Individual;Knock-out;Lasso;Life;Life Cycle Stages;Light;Lipids;Lytic Phase;Mechanics;Mediating;Membrane;Microscopy;Mitochondria;Molecular;Molecular Genetics;Monitor;Morphology;mutant;Mutation Analysis;novel;novel therapeutics;Organelles;Parasites;pathogen;Pharmaceutical Preparations;Phenotype;Phosphorylation Site;Physiology;Plasmodium falciparum;Play;Population;Positioning Attribute;Post-Translational Protein Processing;Process;protein complex;Proteins;Proteomics;Regulation;Research;Resistance;Role;segregation;Shapes;Site;Societies;Stretching;Structure;System;tissue culture;Toxoplasma;Toxoplasma gondii;Toxoplasmosis;Transmembrane Domain;Tubular formation;yeast two hybrid system;Yeasts,Regulation of mitochondrial morphodynamics in Toxoplasma gondii,149766,ZRG1,Special Emphasis Panel[ZRG1-IDM-M(02)M],NA,NA,6,92729,56565,149294,NA
11226108,R03,DK,7,N,2024-11-27,2024-11-27,2025-04-30,847,R03DK135459,SCHOOLS OF MEDICINE,PA-24-254,7R03DK135459-03,NIDDK:107765\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,Aurora,UNITED STATES,NONE,06,041096314,US,1199905,UNIVERSITY OF COLORADO DENVER,CO,800452571,"PROJECT NARRATIVE People with type 1 diabetes suffer chronic complications and are at risk of life-threatening episodes of hypoglycemia and diabetic ketoacidosis. Therapies that increase the number of residual β-cells have been proposed as a strategy to delay or reverse insulin dependence in people with prediabetes or in the “honeymoon” phase of the disease. This research will address whether changes to β-cell metabolism impact the effectiveness of such therapies, opening the possibility for combined drug and dietary interventions to prevent or reverse disease progression.",11741010 (contact),"WORTHAM, MATTHEW  (contact)","GUPTA, DHANANJAY",2023-05-01,2025-04-30,NA,Metabolic requirements of pancreatic beta cell proliferation,135459,ZDK1,ZDK1-GRB-S(J2),NA,NA,3,69080,38685,107765,NA
11228238,Y01,EB,NA,N,NA,NA,NA,NA,AEB24004001,NA,NA,AEB24004001-1-0-1,NIBIB:124425\,INTERAGENCY AGREEMENTS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,NA,NA,NA,NA,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NA,NA,NA,(contact),NA,NA,NA,Acceleration;Area;Clinical;Collaborations;commercialization;data resource;Development;diagnostic technologies;Goals;Government;Home;Industry;innovation;Institution;Knowledge;Medical Imaging;multidisciplinary;network models;new technology;point of care;Point of Care Technology;Readiness;Research;Resources;Technology;technology development;technology research and development,MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) - FDA,240040,NA,NA,NA,NA,NA,NA,NA,124425,NA
11228436,R21,EB,7,N,2024-12-13,2024-11-01,2025-05-31,286,R21EB036153,GRADUATE SCHOOLS,PAR-24-022,7R21EB036153-02,NIBIB:221662\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,NEW YORK,UNITED STATES,BIOPHYSICS,12,071037113,US,7056601,ROCKEFELLER UNIVERSITY,NY,100656399,"PROJECT NARRATIVE Laser scanning microscopy is the standard technique for imaging at depth in thick, scattering tissue. However, further scaling of imaging performance is limited by tissue heating. To circumvent this limit, this project seeks to develop new detection modalities based on nonlinear amplification in optical fibers to improve signal-to-noise ratio, imaging speed, and depth penetration for common techniques including optical coherence tomography, confocal, and multiphoton microscopy; thereby representing a new scaling axis for information capacity.",79226654 (contact),"DEMAS, JEFFREY DAKIN (contact)","ANDERSON, AFROUZ AZARI",2024-09-01,2027-05-31,Adipocytes;Adopted;Adoption;amplification detection;Amplifiers;Area;attenuation;Benchmarking;Biological;biomedical imaging;Bypass;Calibration;Communication;Confocal Microscopy;cost;design;Detection;detection platform;detector;Development;Diameter;Drops;Ensure;Fiber;Fiber Optics;Fluorescence;frontier;Heating;Home;Image;Imaging Techniques;improved;Infrastructure;innovation;Label;Laser Scanning Microscopy;Lasers;Length;Light;light emission;Link;Measures;Methods;Microscope;Modality;multiphoton microscopy;Noise;Optical Coherence Tomography;optical fiber;optical imaging;Optics;parallelization;Penetration;Performance;photomultiplier;photonics;Photons;Procedures;Process;Property;Proteins;Pump;quantum;quantum optics;Research;Resolution;Retina;Sampling;Scanning;Scheme;Signal Transduction;Silicon;Skin;spatiotemporal;Specific qualifier value;Speed;System;Techniques;Technology;Telecommunications;Testing;Thick;Tissue Sample;Tissues;Tube;two-photon,New detection paradigms for laser-scanning microscopy leveraging fiber optical amplifiers,36153,ZRG1,Special Emphasis Panel[ZRG1-BBBT-Y(82)S],NA,NA,2,130774,90888,221662,NA
11228566,R56,EB,7,N,2025-01-10,2024-11-29,2025-11-30,286,R56EB029259,SCHOOLS OF ARTS AND SCIENCES,PA-20-185,7R56EB029259-06,NIBIB:348204\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING,NA,SANTA BARBARA,UNITED STATES,CHEMISTRY,24,094878394,US,577509,UNIVERSITY OF CALIFORNIA SANTA BARBARA,CA,931060001,"PROJECT NARRATIVE Internal targeted radionuclide therapy uses radioactive drugs to destroy tumors and can also be applied for imaging or diagnostic applications. From a therapeutic perspective, those that emit a specific form of radiation called alpha particles are highly effective and have been the subject of many promising clinical trials within recent years, but are generally not amenable for imaging. This project will develop new chemistry to enable the highly efficacious alpha-emitting drugs to be used in conjunction with identical radioactive imaging agents, leading to substantial improvements in patient treatment and diagnosis.",10089410 (contact),"WILSON, JUSTIN J (contact)","ATANASIJEVIC, TATJANA",2020-03-05,2025-11-30,Actinium;Actinoid Series Elements;Address;Alpha Particle Emitter;Alpha Particles;Area;Beta Particle;Binding;Biodistribution;Biological;Bismuth;cancer cell;cancer therapy;Chelating Agents;chelation;chemical property;Chemicals;Chemistry;Clinic;Clinical;clinical development;Clinical Research;Clinical Trials;Complex;cytotoxic;design;Development;Diagnosis;Diagnostic;Diagnostic Imaging;Discipline of Nuclear Medicine;Disease;dosimetry;Drug Approval;Drug Industry;Drug Kinetics;Exhibits;Fluorine;Funding;Half-Life;human disease;Image;imaging agent;improved;in vivo;Indium-111;interest;Ions;Lead;Ligands;Linear Energy Transfer;Metals;Modality;Nature;Nuclear Decay;overexpression;patient response;Patients;Penetration;Pharmaceutical Preparations;Photons;Positron;prevent;Property;Radiation;Radiation therapy;Radioactive;Radioisotopes;Radiolabeled;Radionuclide Imaging;Radionuclide therapy;Radiopharmaceuticals;Radium;receptor;response;Staging;success;System;theranostics;Therapeutic;Therapeutic Agents;Therapeutic Intervention;therapy design;translational potential;Treatment Efficacy;tumor;Uranium;Vanadium;vector;Work,Chelators to Enable Theranostic Alpha Particle Radiotherapeutic Agents,29259,IPCA,Imaging Probes and Contrast Agents Study Section[IPCA],NA,NA,6,263701,84503,348204,NA
11228708,K23,HD,7,N,2024-12-02,2024-12-01,2025-06-30,865,K23HD109471,SCHOOLS OF MEDICINE,PA-24-254,7K23HD109471-03,NICHD:144188\,OTHER RESEARCH-RELATED,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,DALLAS,UNITED STATES,PEDIATRICS,30,800771545,US,578404,UT SOUTHWESTERN MEDICAL CENTER,TX,753909105,PROJECT NARRATIVE Preterm infants (~0.4 million born in the US yearly) are at risk for frequent blood oxygen drops (Intermittent Hypoxemia (IH)) that are linked to multiple short- and long-term neonatal morbidities leading to both lifelong impairments and increased burden on health care cost. Our study investigates both markers and mechanisms of brain injury from increased intermittent hypoxemia in preterm infants. These data will contribute to our understanding of brain injury from intermittent hypoxemia and identify potential targets for developing treatments in the future to improve IH and associated impairments.,14544147 (contact),"ABU JAWDEH, ELIE G (contact)","KOSO-THOMAS, MARION",2023-07-12,2028-06-30,NA,Systemic Mediators and Biomarkers of Injury in Preterm Infants with Intermittent Hypoxemia,109471,CHHD,Pediatrics Study Section[CHHD-A],NA,NA,3,133507,10681,144188,NA
11228745,K23,MD,7,N,2024-11-27,2024-11-27,2026-01-31,307,K23MD016431,SCHOOLS OF NURSING,PA-24-254,7K23MD016431-04,NIMHD:102265\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,ARLINGTON,UNITED STATES,OTHER HEALTH PROFESSIONS,25,064234610,US,578402,UNIVERSITY OF TEXAS ARLINGTON,TX,760190145,"Black pregnant women are more likely to experience racial discrimination and depressive symptoms and have higher risk for vitamin D deficiency and preterm birth (< 37 completed weeks gestation) compared with White women. Identifying the genomic inflammatory pathways that relate racial discrimination, depressive symptoms and vitamin D deficiency with preterm birth may lead to early identification of risk for preterm birth for Black women, and development of interventions to reduce preterm birth disparities among these women.",12594186 (contact),"WOO, JENNIFER  (contact)","MARTIN, IMAN",2022-05-14,2026-01-31,NA,"Genomic signatures of inflammation: Pathways of racial discrimination, depressive symptoms, Vitamin D status with preterm birth among Black women",16431,ZMD1,ZMD1-DRI(J1)1,NA,NA,4,94690,7575,102265,NA
11228816,R44,DC,6,N,2024-11-19,2024-08-03,2025-07-31,173,R44DC019065,NA,PA-23-230,6R44DC019065-03,NIDCD:524299\,SBIR-STTR RPGS,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,OMAHA,UNITED STATES,NA,02,117008613,US,10055005,"TING THERAPEUTICS, INC.",NE,68114,"PROJECT NARRATIVE The work in this proposal focuses on further preclinical development of TT003 to protect from aminoglycoside- induced hearing loss. If successful, this proposal will allow Ting Therapeutics to initiate conversations with pharmaceutical companies for the manufacturing and commercialization of TT003 and for IND-approval by the FDA for its use as a standard otoprotective component of aminoglycoside-based therapies.",6186575 (contact),"ZUO, JIAN  (contact)","MILLER, ROGER",2020-07-17,2027-07-31,Acetylcysteine;Acute;Adult;Aftercare;Aminoglycoside Antibiotics;Aminoglycosides;Animal Model;Animals;Anti-Bacterial Agents;Antioxidants;Attenuated;Audiology;Auditory;Auditory Brainstem Responses;authority;Bacteria;Bacterial Infections;Blood;Capsicum;Cavia;Cell Count;Chemosensitization;Clinical;Clinical Treatment;Clinical Trials;Cochlea;Collection;Colony-forming units;commercial application;commercialization;Contracts;Cystic Fibrosis;cystic fibrosis patients;Cytoprotection;Data;design;Detection;Dose;Drug Interactions;Drug Kinetics;drug testing;Drug usage;ebselen;efficacy study;Endotoxemia;Environment;excitotoxicity;experience;experimental study;Food and Drug Administration Drug Approval;Future;Glutamates;Glutathione Metabolism Pathway;Goals;good laboratory practice;Gram-Negative Bacterial Infections;guinea pig model;Hair Cells;hearing impairment;hearing preservation;Hearing Protection;High Pressure Liquid Chromatography;high throughput screening;Human;in vivo;Inflammation;inflammatory marker;International;Intranasal Administration;intraperitoneal;Investigational Drugs;Investments;Jaborandi Pepper;Kanamycin;Knowledge;Labyrinth;Legal patent;Lipopolysaccharides;manufacture;Mass Spectrum Analysis;Measures;Methodology;Modeling;Morphology;mouse model;Mus;Natural Compound;Natural Products;New Drug Approvals;No-Observed-Adverse-Effect Level;Observational Study;otoacoustic emission;otoprotectant;ototoxicity;Outcome;Patients;Perilymph;Pharmaceutical Preparations;Pharmacodynamics;pharmacokinetics and pharmacodynamics;pharmacologic;Pharmacologic Substance;Phase;phase 1 study;Physiological;Population;Pre-Clinical Model;preclinical development;preclinical study;preclinical trial;prevent;prevent hearing loss;Procedures;Proto-Oncogene Proteins c-akt;Pseudomonas aeruginosa;Pseudomonas aeruginosa infection;Quality of life;Regimen;research clinical testing;Research Contracts;Rights;septic patients;Small Business Innovation Research Grant;Sodium Chloride;STAT3 gene;Study models;technological innovation;Testing;Therapeutic;Therapeutic Index;Time;Toxic effect;Treaty;United States Food and Drug Administration;vitamin metabolism;webinar;Work;Zebrafish,Therapeutics to prevent aminoglycoside-induced hearing loss,19065,ZRG1,Special Emphasis Panel[ZRG1-NV-M(12)B],NA,NA,3,349999,140000,524299,NA
11228819,R44,DC,6,N,2024-12-04,2024-08-02,2024-11-30,173,R44DC018463,NA,PA-20-260,6R44DC018463-05,NIDCD:174684\,SBIR-STTR RPGS,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,OMAHA,UNITED STATES,NA,02,117008613,US,10055005,"TING THERAPEUTICS, INC.",NE,68114,"PROJECT NARRATIVE The work in this proposal focuses on further development of TT001 to protect from cisplatin- induced hearing loss, an anticancer drug that leaves 40-60% of the treated cancer patients with high frequency hearing loss. If successful, this proposal will allow Ting Therapeutics to initiate conversations with pharmaceutical companies for the manufacturing and commercialization of TT001, for its use as a standard otoprotective component of cisplatin-based therapies.",10216138 (contact),"HUANG, YUNLONG  (contact)","MILLER, ROGER",2019-12-09,2024-11-30,Aftercare;Animal Model;Animals;anticancer activity;Antineoplastic Agents;Antioxidants;Audiology;Auditory;Auditory Brainstem Responses;authority;Award;Blood;Cancer cell line;Cancer Patient;cancer therapy;Cavia;CDK2 gene;Cell Death Induction;Cell Line;Chemicals;China;Cisplatin;cisplatin induced hearing loss;Clinical;Clinical Treatment;Clinical Trials;Cochlea;commercial application;commercialization;Contracts;Data;design;Detection;Development;Dose;Drug Kinetics;Drug usage;Ear;efficacy study;Europe;experience;experimental study;Freedom;Future;Glutathione Metabolism Pathway;Goals;good laboratory practice;guinea pig model;Hair Cells;healthy volunteer;hearing impairment;hearing loss treatment;hearing preservation;Hearing Protection;High Pressure Liquid Chromatography;high throughput screening;High-Frequency Hearing Loss;Hong Kong;Human;Immunohistochemistry;in vitro activity;in vivo;inhibitor;International;Investigational Drugs;Japan;Knowledge;Labyrinth;Legal patent;Licensing;Malignant neoplasm of testis;Malignant Neoplasms;manufacture;Mass Spectrum Analysis;Measures;Mediation;Methods;Morphology;mouse model;Mus;neoplastic cell;New Drug Approvals;Observational Study;Oral;otoacoustic emission;otoprotectant;ototoxicity;Outcome;Patients;Perilymph;Pharmaceutical Preparations;Pharmacodynamics;pharmacokinetics and pharmacodynamics;pharmacologic;Pharmacologic Substance;Phase;phase 1 study;preclinical trial;prevent;prevent hearing loss;Procedures;Protocols documentation;Publishing;Quality of life;Regimen;research clinical testing;Research Contracts;Rights;Rodent Model;safety and feasibility;Saint Jude Children&apos;s Research Hospital;Small Business Innovation Research Grant;Sodium Chloride;sodium thiosulfate;technological innovation;Testing;Therapeutic;Therapeutic Index;Time;Toxic effect;Toxicology;tumor;tumor xenograft;United States Food and Drug Administration;vitamin metabolism;webinar;Western Blotting;Work;Xenograft Model,CDK2 inhibitors for protecting hearing loss,18463,ZRG1,Special Emphasis Panel[ZRG1-ETTN-M(12)B],NA,NA,5,116612,46645,174684,NA
11228821,R44,DC,6,N,2024-12-05,2024-08-03,2025-07-31,173,R44DC018762,NA,PA-21-259,6R44DC018762-05,NIDCD:326371\,SBIR-STTR RPGS,2024,NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS,NA,OMAHA,UNITED STATES,NA,02,117008613,US,10055005,"TING THERAPEUTICS, INC.",NE,68114,"PROJECT NARRATIVE The work in this proposal focuses on further preclinical development of TT002 to protect from cisplatin-induced hearing loss. If successful, this proposal will allow Ting Therapeutics to initiate conversations with pharmaceutical companies for the manufacturing and commercialization of TT002 and for IND-approval by the FDA for its use as a standard otoprotective component of cisplatin-based therapies.",10216138 (contact),"HUANG, YUNLONG  (contact)","MILLER, ROGER",2020-04-01,2025-07-31,Adult;Aftercare;Animal Model;Animals;Anthelmintics;anticancer activity;Antineoplastic Agents;Antioxidants;Attenuated;Audiology;Auditory;Auditory Brainstem Responses;authority;Benchmarking;Blood;Cancer cell line;Cancer Patient;Cavia;Cell Line;Cestoda;Chemicals;chemotherapy;Cisplatin;cisplatin induced hearing loss;Clinical;Clinical Treatment;Clinical Trials;Cochlea;commercial application;commercialization;Contracts;Data;design;Detection;Dose;Drug Interactions;Drug Kinetics;Drug Screening;drug testing;Drug usage;efficacy study;experimental study;FDA approved;Food and Drug Administration Drug Approval;Freedom;Future;FVB Mouse;Germany;Glutathione Metabolism Pathway;Goals;good laboratory practice;guinea pig model;Hair Cells;healthy volunteer;hearing impairment;hearing preservation;Hearing Protection;Human;Immunohistochemistry;in silico;In Vitro;in vitro activity;in vivo;International;intraperitoneal;Investigational Drugs;Investments;Knowledge;Labyrinth;Legal patent;Liquid Chromatography;Malignant neoplasm of testis;Malignant Neoplasms;manufacture;Measures;Morphology;mouse model;Mus;neoplastic cell;New Drug Approvals;novel therapeutics;Observational Study;Oral Administration;otoacoustic emission;otoprotectant;ototoxicity;Outcome;Patients;Performance;Perilymph;Pharmaceutical Preparations;Pharmacodynamics;pharmacokinetics and pharmacodynamics;pharmacologic;Pharmacologic Substance;Phase;phase 1 study;preclinical development;preclinical evaluation;preclinical study;preclinical trial;prevent;prevent hearing loss;Procedures;Protocols documentation;Publishing;Quality of life;Regimen;research clinical testing;Research Contracts;Rights;Rodent Model;Safety;safety and feasibility;Small Business Innovation Research Grant;Sodium Chloride;sodium thiosulfate;technological innovation;Testing;Therapeutic;Therapeutic Index;Time;Toxic effect;Toxicology;Treaty;tumor;tumor xenograft;United States Food and Drug Administration;virtual;vitamin metabolism;webinar;Western Blotting;Work;Xenograft Model;Zebrafish,Preclinical evaluation of an otoprotectant TT002,18762,ZRG1,Special Emphasis Panel[ZRG1-ETTN-M(12)B],NA,NA,5,217872,87149,326371,NA
11229103,R01,AI,7,N,2024-12-04,2024-12-01,2025-05-31,855,R01AI165079,SCHOOLS OF MEDICINE,PA-24-254,7R01AI165079-05,NIAID:408072\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,CHICAGO,UNITED STATES,INTERNAL MEDICINE/MEDICINE,05,005436803,US,6144650,NORTHWESTERN UNIVERSITY AT CHICAGO,IL,606114579,"PROJECT NARRATIVE Natural killer cells (also known as NK cells) are a type of white blood cell that can target and kill cancer cells and virally infected cells; however, their functions are dysregulated during HIV infection allowing HIV-infected cells to evade their surveillance. The functions of these NK cells are hindered when a carbohydrate-binding protein called Siglec-9, expressed on their surface, binds to specific carbohydrates expressed on the surface of their target (HIV-infected) cells. We developed a novel approach to prevent this binding and thereby enhance the NK cells' ability to target and kill HIV-infected cells; this approach can be used in conjugation with other approaches to cure HIV infection.",12423100 (contact);14526665,"ABDEL MOHSEN, MOHAMED  (contact);XIAO, HAN","POON, BETTY",2021-06-25,2026-05-31,NA,Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection,165079,HIVD,HIV Immunopathogenesis and Vaccine Development Study Section[HIVD],NA,NA,5,283920,124152,408072,NA
11229645,R01,CA,7,N,2025-01-22,2024-11-09,2025-02-28,393,R01CA285621,NA,PA-24-254,7R01CA285621-02,NCI:246835\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,NEW YORK,UNITED STATES,NA,13,078861598,US,3839801,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,100296574,"PROJECT NARRATIVE The increasingly crucial role played by family and friend caregivers of patients with advanced cancer is complicated by existential distress, but to date, current psychosocial interventions fail to address such distress. This project is relevant to NIH’s mission as it represents a critical step in the refinement of a targeted intervention–Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C)–that has shown encouraging results in improving caregivers’ sense of meaning in life and spiritual wellbeing and ameliorating anxiety and depression. If successful, MCP-C holds significant promise to not only improve the quality of life for caregivers across the caregiving trajectory from diagnosis through bereavement, but also to yield downstream benefits to the patients for whom they provide care.",11077187 (contact),"APPLEBAUM, ALLISON  (contact)","FERRER, REBECCA",2024-01-01,2029-02-28,NA,Meaning-Centered Psychotherapy to Meet Palliative Care Needs of Cancer Caregivers,285621,SPIP,"Social Psychology, Personality and Interpersonal Processes Study Section[SPIP]",NA,NA,2,190031,56804,246835,NA
11230554,R01,AI,7,N,2024-12-23,2024-11-01,2025-06-30,855,R01AI170769,SCHOOLS OF MEDICINE,PA-20-185,7R01AI170769-04,NIAID:334248\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,STONY BROOK,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,01,804878247,US,5992612,STATE UNIVERSITY NEW YORK STONY BROOK,NY,117943362,"PROJECT NARRATIVE Drug therapy is required to treat trypanosomatid parasite infections, yet existing drugs suffer from challenging treatment regimens, emerging drug resistance, and significant gaps in our understanding of their mechanisms of action and trypanocidal targets. The proposed research will use a state-of-the-art genetic screening tool to identify genes whose expression promotes resistance against the clinically relevant anti-trypanosomatid drugs currently in use. The phenotypes imparted by multi-resistance genes will then be evaluated to identify pathways that result in drug resistance and, conversely, cell death, the outcomes of which will be transformative for future drug development in trypanosomatid parasites.",10450643 (contact),"HOVEL-MINER, GALADRIEL ASTRA (contact)","MCGUGAN, GLEN C",2022-07-05,2027-06-30,NA,Dissecting multidrug resistance pathways in Trypanosomatids,170769,ZRG1,Special Emphasis Panel[ZRG1-AIDC-F(83)],NA,NA,4,209560,124688,334248,NA
11230560,R21,AI,7,N,2024-12-27,2024-11-01,2025-07-31,855,R21AI174051,SCHOOLS OF MEDICINE,PA-20-195,7R21AI174051-03,NIAID:199375\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,STONY BROOK,UNITED STATES,MICROBIOLOGY/IMMUN/VIROLOGY,01,804878247,US,5992612,STATE UNIVERSITY NEW YORK STONY BROOK,NY,117943362,"PROJECT NARRATIVE Fexinidazole is the promising first oral monotherapy against Human African Trypanosomiasis and is being explored for the treatment of other trypanosomatid infections, yet its mechanism of action, cytotoxic effects, and potential for drug resistance have not been thoroughly investigated. Here, a state-of-the art forward genetic screen has identified proteins with functions in redox and ROS metabolism in a putative fexinidazole resistance pathway, the specificity of which will be evaluated in this proposal through additional targeted genetic screens. Proteins promoting fexinidazole resistance will be analyzed using an unbiased phenotyping pipeline that will provide functional data, determine the role of ROS and redox in drug resistance, evaluate their potential as novel drug targets, and, ultimately, be transformative in the treatment of trypanosomatid infections.",10450643 (contact),"HOVEL-MINER, GALADRIEL ASTRA (contact)","MCGUGAN, GLEN C",2023-08-01,2025-07-31,NA,Fexinidazole survival genes implicate a novel redox-based mechanism in drug resistance,174051,ZRG1,Special Emphasis Panel[ZRG1-AIDC-B(83)],NA,NA,3,125000,74375,199375,NA
11230626,K01,TW,7,N,2025-01-10,2024-12-01,2025-08-31,989,K01TW012922,NA,PA-24-254,7K01TW012922-02,FIC:186447\,OTHER RESEARCH-RELATED,2024,FOGARTY INTERNATIONAL CENTER,NA,EAST LANSING,UNITED STATES,NA,07,NA,US,10071230,HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES,MI,488242600,"PROJECT NARRATIVE The proposed research focuses on tuberculosis (TB) in Malawian children under five years old (U5s), an age group with unacceptably and disproportionately high mortality from TB. The accuracy of promising new TB diagnostic strategies that utilize non-invasively collected specimens will be evaluated, and the pharmacokinetics of first-line antituberculosis therapy in the face of co-prevalent severe acute malnutrition will be described. This research will provide valuable insights into the diagnosis and management of TB in U5s and set the stage for more expand efforts to fill knowledge gaps in these areas going forward.",16579240 (contact),"VONASEK, BRYAN  (contact)","JESSUP, CHRISTINE",2024-09-20,2029-08-31,NA,Tuberculosis in Malawian children under five years old: exploring non-invasive diagnostic strategies and the impact of malnutrition on treatment pharmacokinetics,12922,ZRG1,Special Emphasis Panel[ZRG1-ICP-W(55)R],NA,NA,2,172961,13486,186447,NA
11230855,F32,HL,7,N,2024-11-27,2024-11-18,2025-09-29,837,F32HL170509,SCHOOLS OF MEDICINE,PA-21-048,7F32HL170509-03,NHLBI:65207\,"TRAINING, INDIVIDUAL",2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,MADISON,UNITED STATES,INTERNAL MEDICINE/MEDICINE,02,161202122,US,578503,UNIVERSITY OF WISCONSIN-MADISON,WI,537151218,"Project Narrative Post-translational modifications, or the structural modification of a protein after it is folded, of key heart contractile proteins (cMyBP-C) lead to the quick and precise regulation of the heart. These modifications appear dysfunctional in cardiac myosin binding protein-C (cMyBP-C) during heart disease. In this proposal, we aim to study the functional consequences of modifying cMyBP-C under normal conditions, elevated stress, and therapeutically treated states of the heart to better understand the consequences of these protein modifications and, ultimately, to determine if altering these modifications can lead to improved heart health.",78352944 (contact),"GREENMAN, ANGELA  (contact)","WANG, WAYNE C",2023-09-30,2026-09-29,NA,The role of S-glutathione in regulating cardiac myosin binding protein-C function,170509,ZRG1,Special Emphasis Panel[ZRG1-F10A-K(20)L],NA,NA,3,65207,0,65207,NA
11231401,R35,GM,7,N,2025-01-16,2025-01-01,2025-04-30,859,R35GM155295,SCHOOLS OF ARTS AND SCIENCES,PA-24-254,7R35GM155295-02,NIGMS:273909\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,SAN ANTONIO,UNITED STATES,CHEMISTRY,20,800189185,US,578416,UNIVERSITY OF TEXAS SAN ANTONIO,TX,782491644,"Project Narrative This program centers on developing new organometallic catalysts that can selectively activate different groups on organic molecules according to the wavelength of light irradiation. This will allow for the iterative synthesis of biological targets in one-pot, facilitating rapid access to chemical libraries for medicinal screening and the optimization of biological function. The new technologies developed in the formation of carbon-carbon bonds will also be amenable to automated synthesis platforms of use in medicinal chemistry laboratories.",78945842 (contact),"SANDFORD, CHRISTOPHER  (contact)","YANG, JIONG",2024-07-01,2029-04-30,NA,Switchable Organometallic Catalysts for Organic Reaction Development,155295,MRAB,Maximizing Investigators’ Research Award B Study Section[MRAB],NA,NA,2,180203,93706,273909,NA
11231422,R43,MD,7,N,2024-12-15,2024-12-15,2025-08-31,307,R43MD018218,NA,PA-24-254,7R43MD018218-02,NIMHD:287580\,SBIR-STTR RPGS,2024,NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES,NA,LORETTO,UNITED STATES,NA,03,080808144,US,10047410,APPLIED UNIVERSAL DYNAMICS CORPORATION,MN,553579536,"Project Narrative Parkinson's disease is the second most common neurodegenerative disease, affecting 1% of Americans older than 65. Parkinson's disease is a complex disease affecting a wide range of organ systems and impacting patients in a variety of ways. The motor features of Parkinson's disease including tremor, gait and balance dysfunction are well known, but non-motor features of Parkinson's disease such as those affecting cognition, sleep, and gut absorption are wide ranging and less well known but have a significant impact on patient quality of life. The management of Parkinson's disease is complex and subspecialty care by a movement disorders neurologist is important for extending quality of life for as long as possible. This project seeks to develop improved technology for use in rural environments to aid in the diagnosis and management of Parkinson's disease patients.",1974394 (contact),"HAVEY, GARY D (contact)","PADGETT, LYNNE SLAUGHTER",2024-09-21,2025-08-31,NA,Ring wearable sensor use for diagnosis and monitoring of Parkinson's disease in underserved rural populations,18218,ZMD1,ZMD1-JT(A1)R,NA,NA,2,191977,76790,287580,NA
11231823,R21,HL,7,N,2024-12-04,2024-12-15,2025-08-31,838,R21HL172011,NA,PA-20-195,7R21HL172011-02,NHLBI:233250\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,SEATTLE,UNITED STATES,NA,07,048682157,US,1531401,SEATTLE CHILDREN'S HOSPITAL,WA,981053901,"Pediatric subglottic stenosis (SGS) is a common disorder that is challenging to diagnose due to a varying clinical spectrum and major limitations in the gold-standard severity grading scale. In this proposal we demonstrate a novel diagnostic pipeline that combines engineering analysis and computer vision algorithms to provide personalized and objective diagnostic measures of stenosed airway physiology. The analysis pipeline is widely adoptable, provides novel precision metrics to guide patient management, and thus has the potential to transform the clinical care of this sensitive population.",14980985 (contact),"BARBOUR, MICHAEL  (contact)","NATARAJAN, ARUNA R",2024-09-01,2026-08-31,NA,Computer-Vision and Computational Fluid Dynamics Analysis Pipeline to Improve Diagnosis in Pediatric Subglottic Stenosis,172011,EITA,Emerging Imaging Technologies and Applications Study Section[EITA],NA,NA,2,132528,100722,233250,NA
11232265,R21,ES,7,N,2025-01-23,2025-01-23,2025-01-31,113,R21ES034919,SCHOOLS OF MEDICINE,PA-24-254,7R21ES034919-03,NIEHS:47850\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,PROVIDENCE,UNITED STATES,BIOCHEMISTRY,01,001785542,US,1003201,BROWN UNIVERSITY,RI,029034202,"Our preliminary findings show that RNA abasic sites are abundant, and they stabilize R-loops to regulate the transcription of noncoding RNA. To understand the scope of gene regulation by RNA abasic sites, we will identify their regulatory role genome-wide, identify the enzymes that form RNA abasic sites, and the bases that are removed to form the abasic sites.",2090371 (contact),"CHEUNG, VIVIAN G (contact)","TYSON, FREDERICK L",2023-02-06,2025-01-31,NA,Determining the role of RNA abasic sites in gene regulation,34919,GCAT,"Genomics, Computational Biology and Technology Study Section[GCAT]",NA,NA,3,30000,17850,47850,NA
11232513,P20,GM,5,N,2024-03-27,2024-07-12,2025-01-31,NA,P20GM139762,NA,PAR-19-313,5P20GM139762-04,NIGMS:38044\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,OMAHA,UNITED STATES,NA,02,053309332,US,1943701,CREIGHTON UNIVERSITY,NE,681780133,NA,78152090 (contact),"RENAULD, JUSTINE MARIE (contact)","KOVBASNJUK, OLGA NIKOLAEVNA",2024-07-12,2026-01-31,NA,Understanding the progression of hearing loss in an endolymphatic hydrops model,139762,ZGM1,ZGM1-RCB-3(C1),6158,NA,4,24991,13053,NA,38044
11233606,F31,AI,7,N,2024-12-20,2024-08-01,2025-01-31,855,F31AI176821,SCHOOLS OF MEDICINE,PA-21-052,7F31AI176821-02,NIAID:21926\,"TRAINING, INDIVIDUAL",2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,Nashville,UNITED STATES,INTERNAL MEDICINE/MEDICINE,05,965717143,US,8721001,VANDERBILT UNIVERSITY,TN,372032408,"PROJECT NARRATIVE Dysregulation of mitochondrial homeostasis is a major contributor to human disease. This project aims to explore the role of mitochondrial dynamics in the innate immune system by investigating the interplay between mitochondrial fission, oxidative stress, and cardiolipin externalization in regulating inflammation and cell death in macrophages. The findings will enhance our understanding of the regulatory role of mitochondrial dynamics in the innate immune system and potentially inform the development of novel therapeutic interventions targeting mitochondrial function and homeostasis.",16507313 (contact),"MARTINEZ, EDUARDO  (contact)","MOITRA, KAROBI",2024-02-01,2027-01-31,NA,Uncovering the role of cardiolipin in promoting gasdermin D-mediated necroptosis and hyperinflammation,176821,ZRG1,Special Emphasis Panel[ZRG1-F07B-G(20)],NA,NA,2,21926,0,21926,NA
11233799,R01,HL,7,N,2025-01-08,2025-01-08,2025-03-31,837,R01HL148081,SCHOOLS OF MEDICINE,PA-24-254,7R01HL148081-05,NHLBI:605317\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,Los Angeles,UNITED STATES,OTHER BASIC SCIENCES,37,072933393,US,7636101,UNIVERSITY OF SOUTHERN CALIFORNIA,CA,900894304,"Project Narrative We have developed techniques to regenerate the injured heart using stem cells that restore pump function but make the heart electrically unstable for several weeks. This proposal aims to solve this electrical instability by reprogramming stem cell metabolism and gene regulation. If successful, these studies can lead to a transformative regenerative therapy that could help millions of patients suffering from heart disease.",1876686 (contact),"MURRY, CHARLES E (contact)","WONG, RENEE P",2021-04-01,2025-03-31,NA,Metabolic and Transcriptional Reprogramming of Cardiac Maturation,148081,ZRG1,Special Emphasis Panel[ZRG1-CCHF-S(01)],NA,NA,5,364649,240668,605317,NA
11234363,P50,CA,5,N,2024-07-29,2024-09-01,2025-08-31,NA,P50CA159981,NA,PAR-18-313,5P50CA159981-10,NCI:378669\,RESEARCH CENTERS,2024,NATIONAL CANCER INSTITUTE,NA,BUFFALO,UNITED STATES,NA,26,824771034,US,3934901,ROSWELL PARK CANCER INSTITUTE CORP,NY,142630001,NA,6265424 (contact);7361159,"MOYSICH, KIRSTEN B. (contact);ODUNSI, KUNLE","BASA JANAKIRAM, NAVEENA",2024-09-01,2026-08-31,NA,Enhancing Personalized Care in Ovarian Cancer Through Prospective Exercise Interventions and AI-Driven Data Integration,159981,ZCA1,ZCA1-RPRB-8(J1)P,6283,NA,10,225130,153539,NA,378669
11235240,R01,CA,7,N,2024-12-19,2024-12-01,2025-11-30,396,R01CA288820,SCHOOLS OF MEDICINE,PA-24-254,7R01CA288820-02,NCI:397668\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,NEW HAVEN,UNITED STATES,UROLOGY,03,043207562,US,9420201,YALE UNIVERSITY,CT,065208327,"PROJECT NARRATIVE Resistance to current AR-targeted therapies poses a significant hurdle in treating advanced prostate cancer (PCa), severely affecting clinical outcomes for patients battling this lethal disease. Our research has identified a prevalent ZNF397 deficiency, observed in 25-40% of PCa patients, which propels the transition of cancer cells from an AR-driven luminal lineage to a TET2-driven lineage plastic state, thereby fostering AR-targeted therapy resistance. This study aims to unravel the molecular mechanism behind ZNF397-deficiency-induced lineage plasticity and AR-targeted therapy resistance, with a goal to develop innovative therapeutic approaches to overcome resistance and benefit patients suffering from this devastating disease.",14536041 (contact),"MU, PING  (contact)","BERA, TAPAN K",2024-12-01,2029-11-30,NA,"Deciphering the Impact of ZNF397-deficiency in Promoting TET2-driven Epigenetic Rewiring, Lineage Plasticity, and Therapy Resistance in Prostate Cancer",288820,MCTB,Mechanisms of Cancer Therapeutics B Study Section[MCTB],NA,NA,2,242455,155213,397668,NA
11237263,K01,HS,7,N,2025-01-06,2025-01-08,2025-09-29,226,K01HS027464,SCHOOLS OF PUBLIC HEALTH,PA-20-067,7K01HS027464-06,AHRQ:117607\,OTHER RESEARCH-RELATED,2024,AGENCY FOR HEALTHCARE RESEARCH AND QUALITY,NA,COLLEGE PARK,UNITED STATES,NONE,04,790934285,US,820102,"UNIV OF MARYLAND, COLLEGE PARK",MD,207420001,"NARRATIVE African American women are disproportionally covered by Medicaid and are at greater risk than non-Hispanic white women of losing insurance coverage after pregnancy and of poor maternal health outcomes. Dr. Steenland will train in domestic health policy, maternal health, and advanced econometric methods to prepare her to complete her research aims and for a career as an independent investigator focused on health policy solutions to reduce poor maternal health outcomes among racial/ethnic minority women. In the proposed research aims, Dr. Steenland will examine the effect of Medicaid expansion on disparities in postpartum insurance coverage nationally, and the effect of Medicaid expansion in Arkansas, the state with the largest coverage gains after Medicaid expansion, on disparities in postpartum health care use in Arkansas.",14630507 (contact),"STEENLAND, MARIA WARD (contact)","WILLIS, TAMARA",2020-09-30,2025-09-29,NA,Reducing Postpartum Health Care Disparities through Increased Insurance Coverage after Childbirth,27464,HCRT,Healthcare Research Training [HCRT],NA,NA,6,108895,8712,117607,NA
11237283,K99,HD,7,N,2025-01-24,2025-01-24,2025-06-30,865,K99HD111686,SCHOOLS OF MEDICINE,PA-24-254,7K99HD111686-03,NICHD:57545\,OTHER RESEARCH-RELATED,2024,EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT,NA,SALT LAKE CITY,UNITED STATES,GENETICS,01,009095365,US,514002,UNIVERSITY OF UTAH,UT,841129049,"PROJECT NARRATIVE Mosaic mutation in sperm is an important source of new mutations and underlies sporadic genetic risk for congenital diseases in offspring, this proposal aims to uncover how mutations in single sperm look like, what impacts they have, and how they accumulate with age. I will obtain training in the related fields of reproductive medicine and human subjects, as well as develop both computational and experimental technologies to study the genomes of individual single sperm and generalize them to other studies. The proposed project will not only advance novel technologies for the analysis of single sperm genomes and detect mosaic variants but will also advance a fundamental understanding of paternal non-clonal sperm mosaicism and predict its significant contributions to child health.",15890122 (contact),"YANG, XIAOXU  (contact)","KENT, TRAVIS JOHN",2023-07-15,2025-06-30,NA,Understanding genomic stability between generations by assessing mutational burdens in single sperms,111686,CHHD,"Reproduction, Andrology, and Gynecology Study Section[CHHD-R]",NA,NA,3,53282,4263,57545,NA
11237397,IK6,VA,7,N,2024-11-25,2024-10-01,2025-03-31,999,IK6BX006529,NA,BX-23-022,7IK6BX006529-02,NA,OTHERS,2024,Veterans Affairs,NA,KANSAS CITY,UNITED STATES,NA,05,844272125,US,481049,KANSAS CITY VA MEDICAL CENTER,MO,641282226,"This proposal addresses a significant healthcare issue that affects Veterans, military personnel, and their families disproportionately. In this regard, the incidence of Inflammatory Bowel Disease (IBD) is increasing in Veterans at disproportionate rates than the general population. Dr. Singh’s research program is focused on the investigation of mechanism/s of IBD to discover novel biomarkers and/or therapeutic targets to curb disease severity in IBD patients, and its progression to colon cancer. Both, IBD and colon cancer represent major clinical challenges in the VA health care system, since effective therapeutic interventions are lacking. Similar to IBD, incidence of PTSD is increasing in Veterans at disproportionate rates. Applicant’s lab aims to provide a better understanding of mechanism/s of increasing risk for PTSD and its causal role in promoting IBD to increase opportunities for the development of novel biomarkers and treatment paradigms.",8644695 (contact),"SINGH, AMAR B (contact)",NA,2024-04-01,2029-03-31,NA,BLRD Research Career Scientist Award Application,6529,ZRD1,ZRD1-RCSR-N(01),NA,NA,2,NA,NA,NA,NA
11237400,I01,VA,7,N,2024-11-25,2024-10-01,2025-03-31,999,I01BX006060,NA,BX-22-007,7I01BX006060-02,NA,NON-SBIR/STTR RPGS,2024,Veterans Affairs,NA,KANSAS CITY,UNITED STATES,NA,05,844272125,US,481049,KANSAS CITY VA MEDICAL CENTER,MO,641282226,"Inflammatory bowel disease (IBD) is a conglomerate of debilitating auto-immune disorders of the gastrointestinal tract, which significantly affect one’s lifestyle including active-duty army personnel and the Veterans. Studies for the Department of Veterans Affairs however found that the incidence of IBD among Veterans has recently increased 2-3 folds. An improved understanding of the causal regulation of this increase in IBD in Veterans can open novel therapeutic opportunities. In this proposal, we will perform “Proof-of-Concept” and mechanistic research to understand the causal role of Gut Microbiota associated with Post-Traumatic Stress Disorder (PTSD) in the Veterans in promoting IBD risk and severity. Critical concepts that will be evaluated include whether PTSD- associated Gut Dysbiosis promotes IBD risk by synergizing with gut barrier dysfunctions. Anticipated outcome from the proposed studies will have significant impact upon the clinical management of IBD, the quality of life of the Veterans IBD patients, and in reducing the economic burden of the VA-hospital system.",8644695 (contact),"SINGH, AMAR B (contact)",NA,2024-04-01,2028-03-31,NA,Role of PTSD associated gut dysbiosis and barrier dysfunctions in promoting IBD in Veterans,6060,ZRD1,ZRD1-GAST-L(01)1,NA,NA,2,NA,NA,NA,NA
11239355,K08,CA,7,N,2025-01-17,2024-12-03,2025-06-30,398,K08CA263541,SCHOOLS OF MEDICINE,PA-24-254,7K08CA263541-05,NCI:193023\,OTHER RESEARCH-RELATED,2024,NATIONAL CANCER INSTITUTE,NA,ATLANTA,UNITED STATES,INTERNAL MEDICINE/MEDICINE,05,066469933,US,2384501,EMORY UNIVERSITY,GA,303221007,"PROJECT NARRATIVE The proposed research is relevant to public health because we aim to improve prognostication for patients with advanced cancer by developing frameworks to integrate clinician intuition with machine learning algorithm- based mortality risk predictions (“human-machine collaborations”), a critical step to better identify patients who may benefit from earlier advance care planning and palliative care. This research proposal will optimize an existing machine learning mortality risk prediction algorithm and methodologically assess strategies to present machine learning estimates to clinicians in order to increase prognostic accuracy, advance care planning, and palliative care among patients with advanced cancer. The project is relevant to the NCI's mission by generating fundamental knowledge to inform clinicians, researchers, and policymakers about effective methods to improve and integrate predictive algorithms into clinical practice, thereby allowing better targeting of evidence-based interventions to improve quality of life for patients with advanced cancer.",15593374 (contact),"PARIKH, RAVI BHARAT (contact)","RADAEV, SERGEY",2021-07-05,2026-06-30,NA,Human-Machine Collaborations to Improve Prognosis and Clinical Decision-Making in Advanced Cancer,263541,NCI,Career Development Study Section (J)[NCI-J],NA,NA,5,178725,14298,193023,NA
11239461,R01,DK,7,N,2024-12-23,2024-12-24,2026-01-31,847,R01DK125047,SCHOOLS OF MEDICINE,PA-24-254,7R01DK125047-06,NIDDK:207778\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,NA,CHARLOTTESVILLE,UNITED STATES,SURGERY,05,065391526,US,1526402,UNIVERSITY OF VIRGINIA,VA,229044195,"Hirschsprung-associated enterocolitis (HAEC) is a life-threatening complication of Hirschsprung Disease, a common cause of intestinal obstruction in the newborn that results from incomplete development of the enteric nervous system. The etiology of HAEC is poorly defined and current treatment remains empiric and directed toward alleviating acute symptoms rather than targeting underlying pathophysiology. This proposal will define the role of dysbiosis in the pathophysiology of HAEC and test novel therapeutic approaches for prevention or treatment of HAEC.",7937685 (contact),"GOSAIN, ANKUSH  (contact)","LOH, KATRINA SHUEH WEN",2020-04-01,2026-01-31,NA,Dysbiosis in Hirschsprung Associated Enterocolitis Pathogenesis,125047,ZRG1,Special Emphasis Panel[ZRG1-SBIB-Q(02)M],NA,NA,6,128655,79123,207778,NA
11240979,P20,GM,5,N,2024-03-28,2024-03-01,2025-02-28,NA,P20GM135000,NA,PAR-19-313,5P20GM135000-04,NIGMS:210000\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,BATON ROUGE,UNITED STATES,NA,06,075050765,US,577907,LOUISIANA STATE UNIV A&M COL BATON ROUGE,LA,708030001,NA,12247056 (contact),"CHAMCHEU, JEAN CHRISTOPHER  (contact)","PEI, WUHONG",2024-12-05,2026-02-28,NA,Development of natural and synthetic compounds as novel potentiators of HSV-1 VC2-GMCSF-based oncolytic viral therapy in Breast Cancer,135000,ZGM1,ZGM1-RCB-9(C1),6733,NA,4,210000,NA,NA,210000
11241187,K08,CA,7,N,2024-12-19,2024-12-15,2025-08-31,398,K08CA270077,SCHOOLS OF MEDICINE,PA-24-254,7K08CA270077-04,NCI:191961\,OTHER RESEARCH-RELATED,2024,NATIONAL CANCER INSTITUTE,NA,ANN ARBOR,UNITED STATES,PATHOLOGY,06,073133571,US,1506502,UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,481091276,"PROJECT NARRATIVE Small cell lung cancer (SCLC) remains relatively refractory to multiple therapeutic modalities, including immune checkpoint blockade, despite its high tumor mutation burden. This proposal seeks to exploit newfound immunologic vulnerabilities of SCLC conferred by epigenetic control of MHC Class I antigen presentation. Rational targeting of distinct immunologic subtypes of SCLC could lead to a deeper understanding of epigenetic modulation of immunogenicity, and, ultimately, novel immunotherapies for this treatment-refractory tumor.",8798307 (contact),"MAHADEVAN, NAVIN  (contact)","BIAN, YANSONG",2022-09-01,2027-08-31,NA,Targeting the immunologic vulnerabilities of small cell lung carcinoma,270077,NCI,Career Development Study Section (J)[NCI-J],NA,NA,4,177742,14219,191961,NA
11244217,K01,DA,7,N,2024-12-23,2024-12-11,2025-03-31,279,K01DA058919,SCHOOLS OF MEDICINE,PA-24-254,7K01DA058919-02,NIDA:134010\,OTHER RESEARCH-RELATED,2024,NATIONAL INSTITUTE ON DRUG ABUSE,NA,CHICAGO,UNITED STATES,BIOCHEMISTRY,05,005436803,US,6144650,NORTHWESTERN UNIVERSITY AT CHICAGO,IL,606114579,"NARRATIVE Psychostimulant use disorder accounts for a third of overdose deaths, however, currently there is no FDA- approved pharmacotherapy to treat it. Recent evidence suggests a role for diet and gut signaling in modulating the dopaminergic reward signaling and SUD behavior. I propose to use a recently developed amphetamine preference assay in Drosophila to identify the environmental factors, like dietary components, as well as signaling pathways that modulate this SUD-related behavior.",12570196 (contact),"TITOS VIVANCOS, IRIS  (contact)","LIN, YU",2024-04-01,2027-03-31,NA,Mechanisms of diet modulating experience-dependent amphetamine preference,58919,MCNP,"Molecular and Cellular Neuropharmacology Study Section
[MCNP]",NA,NA,2,124083,9927,134010,NA
11244248,R01,AI,7,N,2024-12-19,2024-12-01,2025-12-31,855,R01AI150240,SCHOOLS OF MEDICINE,PA-24-254,7R01AI150240-06,NIAID:505519\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES,NA,BLACKSBURG,UNITED STATES,OTHER BASIC SCIENCES,09,003137015,US,8968001,VIRGINIA POLYTECHNIC INST AND ST UNIV,VA,240616100,"Toxoplasma replication is the underlying mechanism by which this parasite causes severe and life-threatening disease. The work proposed here seeks to define how the parasite forms a structure called the inner membrane complex, which is analogous to its skeleton. Data from these studies will also identify novel drug targets.",6100161 (contact),"BLADER, IRA J (contact)","MCGUGAN, GLEN C",2020-01-08,2025-12-31,NA,The Organization and Function of the Toxoplasma Daughter Cell Scaffold,150240,ZRG1,Special Emphasis Panel[ZRG1-IDM-M(02)],NA,NA,6,313987,191532,505519,NA
11244513,P20,GM,5,N,2024-04-22,2024-12-09,2025-02-28,NA,P20GM148326,NA,PAR-19-313,5P20GM148326-02,NIGMS:67272\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,LEXINGTON,UNITED STATES,NA,06,939017877,US,2793601,UNIVERSITY OF KENTUCKY,KY,405260001,NA,10807626 (contact),"PINTO, AMELIA KAHLER (contact)","PEI, WUHONG",2024-12-09,2028-02-29,NA,Changes in Cellular Metabolism Associated with Metabolic Syndrome Increase the Severity of Neurotropic Viral Infections,148326,ZGM1,ZGM1-RCB-4(C1),6814,NA,2,43969,23303,NA,67272
11245983,I01,VA,7,N,2024-12-11,2024-11-01,2025-03-31,999,I01BX005889,NA,BX-22-001,7I01BX005889-03,NA,NON-SBIR/STTR RPGS,2024,Veterans Affairs,NA,AUGUSTA,UNITED STATES,NA,12,010116408,US,481024,CHARLIE NORWOOD VA MEDICAL CENTER,GA,309046285,"Pulmonary fibrosis is a devastating illness that involves progressive remodeling and scarring of lung tissue that can eventually lead to poor gas exchange. The incidence of idiopathic pulmonary fibrosis is increasing worldwide, including among Veterans, mortality rates are high, and the average life expectancy is 3 to 5 years after diagnosis. This proposed study will investigate a previously unrecognized mechanistic pathway that contributes to the development of pulmonary fibrosis and will identify potential targets for therapeutic intervention to reduce fibrosis.",1860187 (contact),"WATERS, CHRISTOPHER M (contact)",NA,2023-04-01,2027-03-31,NA,Sex differences in ASK1-mediated pulmonary fibrosis,5889,ZRD1,ZRD1-PULM-N(01)1,NA,NA,3,NA,NA,NA,NA
11246676,R01,CA,7,N,2025-01-03,2025-01-01,2025-12-31,393,R01CA261887,SCHOOLS OF MEDICINE,RFA-CA-20-027,7R01CA261887-04,NCI:697367\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,ATLANTA,UNITED STATES,PSYCHIATRY,05,066469933,US,2384501,EMORY UNIVERSITY,GA,303221007,"Narrative This multi-site collaboration will assess pediatric, adolescent, and young adult survivors (PAYAS) of cerebellar medulloblastoma (MB) and the unique contributions of (1) Environmental resources (e.g., area deprivation, material hardships, caregiver capacity, school quality), (2) clinical factors (e.g., MB molecular tumor type, treatment level, age) and (3) individual genetic diathesis (i.e., targeted single nucleotide polymorphism variants (SNPs) using gene and RNA sequencing association), as independent risk factors for cognitive impairment (CI). Further, we will create a multi-domain risk algorithm, using the most sensitive predictors of CI across the three domains, in order to create a multifactorial measure that best captures the biopsychosocial markers of CI outcomes in PAYAS of MB. Consistent with the STAR Act of 2018 and the Precision Medicine Initiative, this research will inform the development of risk- adapted chemoradiation treatment and preemptive interventions to prevent, mitigate and manage CI to optimize outcomes and improve overall quality of life in PAYAS of childhood cancer.",6436027 (contact),"KING, TRICIA Z. (contact)","DAEE, DANIELLE L",2022-07-05,2027-12-31,NA,Outcomes in AYA survivors of pediatric medulloblastoma.,261887,ZCA1,ZCA1-SRB-T(J1),NA,NA,4,522786,174581,697367,NA
11246948,IK2,VA,7,N,2024-12-11,2024-10-01,2025-03-31,999,IK2BX004910,NA,BX-20-023,7IK2BX004910-05,NA,OTHERS,2024,Veterans Affairs,NA,MADISON,UNITED STATES,NA,02,086683091,US,481071,WM S. MIDDLETON MEMORIAL VETERANS HOSP,WI,537052254,"Hearing loss and tinnitus are the most common service-related disabilities for veterans. These disabilities span decades, conflicts, geographic location, and job descriptions. For those patients who have hearing loss too severe to benefit from hearing aids, cochlear implants offer a chance to regain some hearing and even understand speech without reading lips. However, current electrode technology cannot approach natural hearing. We propose applying living scaffold technology to the central and peripheral auditory system to create an implantable hearing device that provides more natural hearing than is possible with current technology. Living electrodes will be created by growing spiral ganglion neurons on to constructs designed to be implanted in the cochlea or auditory nuclei in the brainstem. These studies promise to deliver a significant advance in the ability to restore hearing to veterans, and people around the world.",14846918 (contact),"BRANT, JASON  (contact)",NA,2021-04-01,2026-03-31,NA,Living electrodes for auditory rehabilitation.,4910,ZRD1,ZRD1-NURF-H(01),NA,NA,5,NA,NA,NA,NA
11247216,R01,CA,7,N,2024-12-19,2024-12-19,2025-08-31,393,R01CA273458,SCHOOLS OF MEDICINE,PA-24-254,7R01CA273458-03,NCI:254267\,NON-SBIR/STTR RPGS,2024,NATIONAL CANCER INSTITUTE,NA,STONY BROOK,UNITED STATES,PATHOLOGY,01,804878247,US,5992612,STATE UNIVERSITY NEW YORK STONY BROOK,NY,117943362,PROJECT NARRATIVE This proposal will use genome-wide approaches to investigate transcription-coupled DNA repair in eukaryotes. Studies proposed in this application will help us understand mechanisms of the neurological disorder Cockayne syndrome (CS) and cancer mutagenesis.  ,12443118 (contact),"MAO, PENG  (contact)","OKANO, PAUL",2023-04-04,2028-08-31,NA,Mechanism of Transcription-coupled DNA Repair and its Impact on Cancer Mutations,273458,MG,Molecular Genetics Study Section[MG],NA,NA,3,159415,94852,254267,NA
11247411,R21,AA,7,N,2025-01-16,2024-01-15,2025-05-31,273,R21AA030590,ORGANIZED RESEARCH UNITS,PA-24-254,7R21AA030590-03,NIAAA:176938\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM,NA,EUGENE,UNITED STATES,PSYCHOLOGY,04,079289626; 948117312,US,6297005,UNIVERSITY OF OREGON,OR,974035219,"PROJECT NARRATIVE Heavy and frequent alcohol use remains a key public health concern, particularly among young adults. The proposed work will collect intensive momentary assessment data to examine associations between higher-risk alcohol use episodes (binge, high-intensity, blackout drinking) and multiple indices of next-day (post- intoxication) cognitive functioning. By identifying the acute impacts of varying levels of alcohol use intensity on next-day cognitive functioning as well as the day- and person-level characteristics that moderate these associations, our findings will have critical implications for the role of alcohol use on everyday cognitive functioning and highlight subgroups most in need of monitoring and early intervention.",11822603 (contact),"LINDEN-CARMICHAEL, ASHLEY NICOLE (contact)","KERRIDGE, BRADLEY TOWNSEND",2024-01-15,2025-05-31,NA,An Ecological Investigation of Acute Next-Day Effects of Alcohol Use on Daily Cognitive Functioning,30590,AA,"Epidemiology, Prevention and Behavior Research Study Section[AA-2]",NA,NA,3,118750,58188,176938,NA
11247769,P20,GM,2,N,2024-08-29,2024-09-01,2025-07-31,NA,P20GM130414,NA,PAR-23-063,2P20GM130414-06,NIGMS:239201\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,PROVIDENCE,UNITED STATES,NA,01,001785542,US,1003201,BROWN UNIVERSITY,RI,029034202,NA,14146602 (contact),"SOKOLOVSKY, ALEXANDER WILLIAM (contact)","PEI, WUHONG",2024-09-01,2029-07-31,NA,Using wearables and EMA to examine the links between cannabis and depression,130414,ZGM1,Special Emphasis Panel[ZGM1 RCB-3 (C2)],7005,NA,6,149969,89232,NA,239201
11247893,U01,IP,6,N,2024-12-11,2024-08-01,2025-07-31,083,U01IP001265,NA,RFA-IP-24-045,6U01IP001265-01M001,NCIRD:484260\,NON-SBIR/STTR RPGS,2024,NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES,NA,SEATTLE,UNITED STATES,NA,07,605799469,US,9087701,UNIVERSITY OF WASHINGTON,WA,981959472,NA,10250308 (contact),"CHU, HELEN YING-HUI (contact)",NA,2024-08-01,2029-07-31,NA,"IP24-045, SEAPREP:  Seattle Pandemic Preparedness Cohort",1265,ZIP1,ZIP1-GCA(63),NA,M001,1,NA,NA,484260,NA
11248214,R00,ES,7,N,2025-01-23,2025-01-23,2025-07-31,113,R00ES033259,OVERALL MEDICAL,PA-24-254,7R00ES033259-05,NIEHS:176635\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,COLLEGE STATION,UNITED STATES,GENETICS,10,835607441,US,8266910,TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,TX,778454375,"PROJECT NARRATIVE The health effects associated with low-dose arsenic are controversial, and our knowledge of the molecular mechanisms underlying different individuals’ susceptibility to low-dose arsenic is limited. The proposed study will bring mechanistic insights to arsenic, aquaporin 3–induced DNA damage and mutations, highlighting the importance of studying the mechanisms underlying individual susceptibility to low-dose arsenic. This project will also identify potential early genomic biomarkers to predict long-term arsenic toxicology.",15096777 (contact),"XIA, JUN  (contact)","SHAUGHNESSY, DANIEL",2022-08-15,2025-07-31,NA,The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis,33259,ZES1,ZES1-SRC(99),NA,NA,5,121785,54850,176635,NA
11248960,U2F,FD,7,N,2024-12-23,2024-07-01,2025-06-30,103,U2FFD008044,NA,RFA-FD-23-019,7U2FFD008044-03,FDA:225000\,NON-SBIR/STTR RPGS,2024,FOOD AND DRUG ADMINISTRATION,NA,COLUMBIA,UNITED STATES,NA,06,197238199,US,10006566,SC STATE DEPARTMENT OF AGRICULTURE,SC,292013734,"Project Narrative - SCRRT Maintenance Track  FOA Number: RFA-FD-23-019; Application ID: 1417421  Research and Related Other Project Information Form, Field #8 By the end of our current five-year cooperative agreement, the South Carolina Department of Health and Environmental Control (DHEC), with assistance from the South Carolina Department of Agriculture (SCDA), will have fully developed the South Carolina Rapid Response Team (SCRRT) based on national standardized objectives. If awarded this cooperative agreement, DHEC will improve our methods for protecting public health by collaborating with SCDA to successfully maintain the SCRRT and improve our processes over the three-year period. The SCRRT, a multi-disciplinary, multi-agency team composed of DHEC, SCDA, and other key state agencies, will work collaboratively to respond to all human and animal food (HAF) incidents and outbreaks to secure the safety of South Carolina’s food supply.",15006611 (contact),"DORTON, ELIZABETH  (contact)","ANDREWS, THANH",2023-09-01,2026-06-30,NA,Continuation of Cooperative Agreement between U.S. Food and Drug Administration and S.C. Department of Health and Environmental Control (DHEC) for RRT Maintenance.,8044,ZFD1,ZFD1-ORA-J(06)1,NA,NA,3,204545,20455,225000,NA
11249307,R35,HL,7,N,2025-01-21,2025-01-15,2025-04-30,837,R35HL150713,NA,PA-24-254,7R35HL150713-06,NHLBI:368911\,NON-SBIR/STTR RPGS,2024,"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE",NA,MADISON,UNITED STATES,NA,02,012420082,US,10023197,"MORGRIDGE INSTITUTE FOR RESEARCH, INC.",WI,537151119,"PROJECT NARRATIVE The discoveries we make will continue to inform the fundamental biology of heart regeneration, and they will directly relate to ideas and methods to enhance regeneration and reduce the incidence of heart failure in humans. They are also likely to extend beyond cardiovascular biology and have relevance to the repair of other tissues.",1881084 (contact),"POSS, KENNETH D (contact)","SHI, YANG",2020-05-15,2027-04-30,NA,Leveraging zebrafish models to dissect and enhance heart regeneration,150713,ZHL1,ZHL1-CSR-R(O1),NA,NA,6,204951,163960,368911,NA
11249862,R00,ES,7,N,2025-01-16,2025-01-15,2025-03-31,113,R00ES032892,SCHOOLS OF MEDICINE,PA-24-254,7R00ES032892-05,NIEHS:59527\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES,NA,SAN FRANCISCO,UNITED STATES,OBSTETRICS & GYNECOLOGY,11,094878337,US,577508,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,941432510,"PROJECT NARRATIVE  Advances in high-resolution mass spectrometry (HRMS) offer unique opportunities to study the human exposome and the development of adverse health outcomes. Despite advances in non-targeted analysis, the number of confirmed chemicals remains fairly limited compared to the number of detected chemical features. The goal of this proposal is to develop novel computational methods to derive chemical structures and apply them to a large dataset of HRMS data from blood samples of pregnant women to study the influence of the exposome on pregnancy outcomes with a focus on preterm birth.",16073505 (contact),"ABRAHAMSSON, DIMITRI  (contact)","CUI, YUXIA",2021-04-16,2026-03-31,NA,Non-target analysis of maternal and cord blood samples: Advancing computational tools and discovering novel chemicals,32892,NSS,NSS,NA,NA,5,36297,23230,59527,NA
11251396,R01,GM,7,N,2025-01-24,2024-09-01,2026-01-31,859,R01GM135651,NA,PA-24-254,7R01GM135651-06,NIGMS:203969\,NON-SBIR/STTR RPGS,2024,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,NA,BALTIMORE,UNITED STATES,NA,07,001910777,US,4134401,JOHNS HOPKINS UNIVERSITY,MD,212182680,"Project Narrative Human non-homologous end joining (NHEJ) pathway represents the predominant repair mechanism for dealing with double strand breaks (DSBs) throughout the entire cell cycle. Its understanding is of great importance for cancer etiology and cancer therapy, due to its significant role in maintaining genome stability and protecting cells from becoming cancerous. Through structural and functional studies, we seek to define the complex molecular mechanisms of NHEJ so that they may be targeted to develop improved approaches to antitumor therapy.",10200931 (contact),"HE, YUAN  (contact)","MACARTHUR, LINDA",2024-09-01,2026-01-31,NA,Structure and Mechanism of Non-Homologous End Joining,135651,MSFC,Macromolecular Structure and Function C Study Section[MSFC],NA,NA,6,137668,66301,203969,NA
11251716,U01,CK,6,N,2024-12-23,2024-09-30,2025-09-29,084,U01CK000666,NA,RFA-CK-22-001,6U01CK000666-03M002,NCEZID:725000\,NON-SBIR/STTR RPGS,2024,National Center for Emerging and Zoonotic Infectious Diseases,NA,KINSHASA,CONGO DEM REP,NA,NA,565493868,CG,10002505,KINSHASA SCHOOL OF PUBLIC HEALTH,NA,11850,"Project Narrative Zoonotic diseases like Monkeypox and Ebola virus disease are a significant public health threat in Democratic Republic of the Congo (DRC) and have a high risk of international exportation. This project aims to improve the ability of DRC to respond to zoonotic diseases by developing rigorous surveillance systems, investigating medical countermeasures and clinical treatments, identifying key risk factors in primary transmission of disease, and creating a resilient interdisciplinary public health workforce.",16299234 (contact),"KABA, DIDINE KINKODI (contact)",NA,2022-09-30,2027-09-29,NA,"RFA-CK-22-001, Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) - 2022",666,ZCK1,ZCK1-GCA(51)R,NA,M002,3,NA,NA,725000,NA
11260089,U54,NS,3,N,2025-01-24,2024-09-01,2025-08-31,NA,U54NS123746,NA,PA-23-189,3U54NS123746-04S1,NINDS:83873\,RESEARCH CENTERS,2024,NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE,NA,LOS ANGELES,UNITED STATES,NA,36,092530369,US,577505,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,900952000,NA,9560183 (contact),"CHANG, TIMOTHY S (contact)","SHEWMAKER, FRANK PAUL",2021-09-01,2026-08-31,NA,Core D: Data,123746,ZNS1,ZNS1,7593,S1,4,83873,0,NA,83873
11261511,U01,IP,6,N,2025-01-16,2024-08-01,2025-07-31,083,U01IP001257,NA,RFA-IP-24-045,6U01IP001257-01M001,NCIRD:893037\,NON-SBIR/STTR RPGS,2024,NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES,NA,BOSTON,UNITED STATES,NA,07,071723621,US,758101,BETH ISRAEL DEACONESS MEDICAL CENTER,MA,022155400,NA,10202650 (contact),"STEPHENSON, KATHRYN ELAINE (contact)",NA,2024-08-01,2029-07-31,NA,"IP24-045, A Prospective Observational Study of Respiratory Virus Epidemiology in the Greater Boston Area",1257,ZIP1,ZIP1-GCA(63),NA,M001,1,NA,NA,893037,NA
11261515,U01,IP,6,N,2025-01-16,2024-08-01,2025-07-31,083,U01IP001238,SCHOOLS OF MEDICINE,RFA-IP-24-045,6U01IP001238-01M001,NCIRD:893037\,NON-SBIR/STTR RPGS,2024,NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES,NA,LA JOLLA,UNITED STATES,OBSTETRICS & GYNECOLOGY,50,804355790,US,577507,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",CA,920930621,NA,9491679 (contact),"LAURENT, LOUISE CHANG (contact)",NA,2024-08-01,2029-07-31,NA,"IP24-045, PREVENT: Preparedness through Respiratory Virus Epidemiology and Community Engagement",1238,ZIP1,ZIP1-GCA(63),NA,M001,1,NA,NA,893037,NA
11261874,U01,IP,6,N,2025-01-16,2024-08-01,2025-07-31,083,U01IP001265,NA,RFA-IP-24-045,6U01IP001265-01M002,NCIRD:893037\,NON-SBIR/STTR RPGS,2024,NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES,NA,SEATTLE,UNITED STATES,NA,07,605799469,US,9087701,UNIVERSITY OF WASHINGTON,WA,981959472,NA,10250308 (contact),"CHU, HELEN YING-HUI (contact)",NA,2024-08-01,2029-07-31,NA,"IP24-045, SEAPREP:  Seattle Pandemic Preparedness Cohort",1265,ZIP1,ZIP1-GCA(63),NA,M002,1,NA,NA,893037,NA
